,date,title,url
0,2002-10-24,亚宝药业总经理工作细则,/disclosure/listedinfo/announcement/c/2002-10-24/600351_20021024_1.pdf
1,2002-10-24,亚宝药业信息披露制度,/disclosure/listedinfo/announcement/c/2002-10-24/600351_20021024_2.pdf
2,2002-10-24,亚宝药业股东大会议事规则,/disclosure/listedinfo/announcement/c/2002-10-24/600351_20021024_3.pdf
3,2002-10-24,亚宝药业独立董事工作制度,/disclosure/listedinfo/announcement/c/2002-10-24/600351_20021024_4.pdf
4,2002-10-24,亚宝药业董事会议事规则,/disclosure/listedinfo/announcement/c/2002-10-24/600351_20021024_5.pdf
5,2002-10-24,亚宝药业第三季度季报,/disclosure/listedinfo/announcement/c/2002-10-24/600351_2002_3.pdf
6,2003-04-08,亚宝药业年报,/disclosure/listedinfo/announcement/c/2003-04-08/600351_2002_n.pdf
7,2003-04-25,亚宝药业第一季度季报,/disclosure/listedinfo/announcement/c/2003-04-25/600351_2003_1.pdf
8,2003-04-26,亚宝药业回访报告,/disclosure/listedinfo/announcement/c/2003-04-26/600351_20030426_1.pdf
9,2003-05-13,亚宝药业股东大会决议公告,/disclosure/listedinfo/announcement/c/2003-05-13/600351_20030513_1.pdf
10,2003-06-27,亚宝药业股东大会决议公告,/disclosure/listedinfo/announcement/c/2003-06-27/600351_20030627_1.pdf
11,2003-08-13,亚宝药业半年报,/disclosure/listedinfo/announcement/c/2003-08-13/600351_2003_z.pdf
12,2003-10-29,亚宝药业投资者关系管理制度,/disclosure/listedinfo/announcement/c/2003-10-29/600351_20031029_1.pdf
13,2003-10-29,亚宝药业第三季度季报,/disclosure/listedinfo/announcement/c/2003-10-29/600351_2003_3.pdf
14,2004-02-06,亚宝药业国家股股权转让批复公告,/disclosure/listedinfo/announcement/c/2004-02-06/600351_20040206_1.pdf
15,2004-03-02,亚宝药业年报,/disclosure/listedinfo/announcement/c/2004-03-02/600351_2003_n.pdf
16,2004-03-02,亚宝药业监事会决议公告,/disclosure/listedinfo/announcement/c/2004-03-02/600351_20040302_3.pdf
17,2004-03-02,亚宝药业公告,/disclosure/listedinfo/announcement/c/2004-03-02/600351_20040302_4.pdf
18,2004-03-02,亚宝药业董事会决议公告暨召开2003年度股东大会通知,/disclosure/listedinfo/announcement/c/2004-03-02/600351_20040302_2.pdf
19,2004-03-02,亚宝药业董事、监事年度薪酬实施办法,/disclosure/listedinfo/announcement/c/2004-03-02/600351_20040302_1.pdf
20,2004-03-05,亚宝药业国家股股权转让过户完成公告,/disclosure/listedinfo/announcement/c/2004-03-05/600351_20040305_1.pdf
21,2004-04-07,亚宝药业第二次回访报告,/disclosure/listedinfo/announcement/c/2004-04-07/600351_20040407_1.pdf
22,2004-04-16,亚宝药业提供担保公告,/disclosure/listedinfo/announcement/c/2004-04-16/600351_20040416_3.pdf
23,2004-04-16,亚宝药业董事会战略委员会工作细则,/disclosure/listedinfo/announcement/c/2004-04-16/600351_20040416_5.pdf
24,2004-04-16,亚宝药业董事会决议公告,/disclosure/listedinfo/announcement/c/2004-04-16/600351_20040416_2.pdf
25,2004-04-16,亚宝药业第一季度季报,/disclosure/listedinfo/announcement/c/2004-04-16/600351_2004_1.pdf
26,2004-04-16,亚宝药业2003年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2004-04-16/600351_20040416_1.pdf
27,2004-04-16,亚宝药业2003年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2004-04-16/600351_20040416_4.pdf
28,2004-05-19,亚宝药业2003年度利润分配及转增股本实施公告,/disclosure/listedinfo/announcement/c/2004-05-19/600351_20040519_1.pdf
29,2004-08-26,亚宝药业高级管理人员年度薪酬实施办法,/disclosure/listedinfo/announcement/c/2004-08-26/600351_20040826_2.pdf
30,2004-08-26,亚宝药业董事会决议公告,/disclosure/listedinfo/announcement/c/2004-08-26/600351_20040826_1.pdf
31,2004-08-26,亚宝药业半年报摘要,/disclosure/listedinfo/announcement/c/2004-08-26/600351_2004_zzy.pdf
32,2004-08-26,亚宝药业半年报,/disclosure/listedinfo/announcement/c/2004-08-26/600351_2004_z.pdf
33,2004-10-12,亚宝药业收购报告书摘要,/disclosure/listedinfo/announcement/c/2004-10-12/600351_20041012_3.pdf
34,2004-10-12,亚宝药业关于控股股东整体改制的提示性公告,/disclosure/listedinfo/announcement/c/2004-10-12/600351_20041012_1.pdf
35,2004-10-12,亚宝药业股东减持持股变动报告书,/disclosure/listedinfo/announcement/c/2004-10-12/600351_20041012_2.pdf
36,2004-10-22,亚宝药业董事会决议公告暨召开临时股东大会的通知,/disclosure/listedinfo/announcement/c/2004-10-22/600351_20041022_1.pdf
37,2004-10-22,亚宝药业第三季度季报,/disclosure/listedinfo/announcement/c/2004-10-22/600351_2004_3.pdf
38,2004-12-01,亚宝药业2004年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2004-12-01/600351_20041201_1.pdf
39,2004-12-01,亚宝药业2004年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2004-12-01/600351_20041201_2.pdf
40,2005-01-26,亚宝药业关于控股股东整体改制进展情况的公告,/disclosure/listedinfo/announcement/c/2005-01-26/600351_20050126_1.pdf
41,2005-03-01,亚宝药业年报摘要,/disclosure/listedinfo/announcement/c/2005-03-01/600351_2004_nzy.pdf
42,2005-03-01,亚宝药业年报,/disclosure/listedinfo/announcement/c/2005-03-01/600351_2004_n.pdf
43,2005-03-01,亚宝药业监事会决议公告,/disclosure/listedinfo/announcement/c/2005-03-01/600351_20050301_2.pdf
44,2005-03-01,亚宝药业董事会决议公告,/disclosure/listedinfo/announcement/c/2005-03-01/600351_20050301_1.pdf
45,2005-04-26,亚宝药业上市公司章程,/disclosure/listedinfo/announcement/c/2005-04-26/600351_20050426_g.pdf
46,2005-04-26,亚宝药业监事会议事规则,/disclosure/listedinfo/announcement/c/2005-04-26/600351_20050426_6.pdf
47,2005-04-26,亚宝药业监事会决议公告,/disclosure/listedinfo/announcement/c/2005-04-26/600351_20050426_2.pdf
48,2005-04-26,亚宝药业股东大会议事规则,/disclosure/listedinfo/announcement/c/2005-04-26/600351_20050426_4.pdf
49,2005-04-26,亚宝药业独立董事工作制度,/disclosure/listedinfo/announcement/c/2005-04-26/600351_20050426_5.pdf
50,2005-04-26,亚宝药业董事会议事规则,/disclosure/listedinfo/announcement/c/2005-04-26/600351_20050426_3.pdf
51,2005-04-26,亚宝药业董事会决议公告暨召开2004年度股东大会的通知,/disclosure/listedinfo/announcement/c/2005-04-26/600351_20050426_1.pdf
52,2005-04-26,亚宝药业第一季度季报,/disclosure/listedinfo/announcement/c/2005-04-26/600351_2005_1.pdf
53,2005-05-27,亚宝药业上市公司章程,/disclosure/listedinfo/announcement/c/2005-05-27/600351_20050527_g.pdf
54,2005-05-27,亚宝药业监事会决议公告,/disclosure/listedinfo/announcement/c/2005-05-27/600351_20050527_4.pdf
55,2005-05-27,亚宝药业董事会决议公告,/disclosure/listedinfo/announcement/c/2005-05-27/600351_20050527_2.pdf
56,2005-05-27,亚宝药业2004年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2005-05-27/600351_20050527_1.pdf
57,2005-05-27,亚宝药业2004年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2005-05-27/600351_20050527_3.pdf
58,2005-07-25,亚宝药业2004年度分红派息实施公告,/disclosure/listedinfo/announcement/c/2005-07-25/600351_20050725_1.pdf
59,2005-08-10,亚宝药业半年报摘要,/disclosure/listedinfo/announcement/c/2005-08-10/600351_2005_zzy.pdf
60,2005-08-10,亚宝药业半年报,/disclosure/listedinfo/announcement/c/2005-08-10/600351_2005_z.pdf
61,2005-08-16,亚宝药业控股股东整体改制进展情况的公告,/disclosure/listedinfo/announcement/c/2005-08-16/600351_20050816_1.pdf
62,2005-09-15,亚宝药业关于公司控股股东整体改制进展情况的公告,/disclosure/listedinfo/announcement/c/2005-09-15/600351_20050915_1.pdf
63,2005-10-26,亚宝药业第三季度季报,/disclosure/listedinfo/announcement/c/2005-10-26/600351_2005_3.pdf
64,2005-12-17,亚宝药业董事会决议公告,/disclosure/listedinfo/announcement/c/2005-12-17/600351_20051217_1.pdf
65,2005-12-23,亚宝药业关于召开2006年第一次临时股东大会暨相关股东会议的通知,/disclosure/listedinfo/announcement/c/2005-12-23/600351_20051223_2.pdf
66,2005-12-23,亚宝药业股权分置改革之保荐意见书,/disclosure/listedinfo/announcement/c/2005-12-23/600351_20051223_5.pdf
67,2005-12-23,亚宝药业股权分置改革相关事项的独立董事意见书,/disclosure/listedinfo/announcement/c/2005-12-23/600351_20051223_7.pdf
68,2005-12-23,亚宝药业股权分置改革说明书（摘要）,/disclosure/listedinfo/announcement/c/2005-12-23/600351_20051223_4.pdf
69,2005-12-23,亚宝药业股权分置改革说明书,/disclosure/listedinfo/announcement/c/2005-12-23/600351_20051223_3.pdf
70,2005-12-23,亚宝药业股权分置改革的法律意见书,/disclosure/listedinfo/announcement/c/2005-12-23/600351_20051223_6.pdf
71,2005-12-23,亚宝药业董事会投票委托征集函,/disclosure/listedinfo/announcement/c/2005-12-23/600351_20051223_8.pdf
72,2005-12-23,亚宝药业董事会决议公告,/disclosure/listedinfo/announcement/c/2005-12-23/600351_20051223_1.pdf
73,2006-01-05,亚宝药业关于股权分置改革方案沟通协商情况暨调整股权分置改革方案的公告,/disclosure/listedinfo/announcement/c/2006-01-05/600351_20060105_2.pdf
74,2006-01-05,亚宝药业股权分置改革之补充保荐意见,/disclosure/listedinfo/announcement/c/2006-01-05/600351_20060105_5.pdf
75,2006-01-05,亚宝药业股权分置改革说明书摘要（修订稿）,/disclosure/listedinfo/announcement/c/2006-01-05/600351_20060105_4.pdf
76,2006-01-05,亚宝药业股权分置改革说明书（修订稿）,/disclosure/listedinfo/announcement/c/2006-01-05/600351_20060105_3.pdf
77,2006-01-05,亚宝药业股权分置改革的补充法律意见书,/disclosure/listedinfo/announcement/c/2006-01-05/600351_20060105_6.pdf
78,2006-01-05,亚宝药业独立董事关于调整股权分置改革方案的补充意见函,/disclosure/listedinfo/announcement/c/2006-01-05/600351_20060105_7.pdf
79,2006-01-05,亚宝药业董事会决议公告,/disclosure/listedinfo/announcement/c/2006-01-05/600351_20060105_1.pdf
80,2006-01-11,亚宝药业董事会关于召开2006年第一次临时股东大会暨相关股东会议的第一次提示性公告,/disclosure/listedinfo/announcement/c/2006-01-11/600351_20060111_1.pdf
81,2006-01-19,亚宝药业关于股权分置改革方案获山西省人民政府国有资产监督管理委员会批准的公告,/disclosure/listedinfo/announcement/c/2006-01-19/600351_20060119_2.pdf
82,2006-01-19,亚宝药业董事会关于召开2006年第一次临时股东大会暨相关股东会议的第二次提示性公告,/disclosure/listedinfo/announcement/c/2006-01-19/600351_20060119_1.pdf
83,2006-01-25,亚宝药业关于因股权分置改革减少注册资本事宜的债权人公告,/disclosure/listedinfo/announcement/c/2006-01-25/600351_20060125_2.pdf
84,2006-01-25,亚宝药业2006年第一次临时股东大会暨相关股东会议的法律意见书,/disclosure/listedinfo/announcement/c/2006-01-25/600351_20060125_3.pdf
85,2006-01-25,亚宝药业2006年第一次临时股东大会暨相关股东会议表决结果的公告,/disclosure/listedinfo/announcement/c/2006-01-25/600351_20060125_1.pdf
86,2006-02-13,亚宝药业股权分置改革方案实施公告,/disclosure/listedinfo/announcement/c/2006-02-13/600351_20060213_1.pdf
87,2006-03-28,G亚宝年报摘要,/disclosure/listedinfo/announcement/c/2006-03-28/600351_2005_nzy.pdf
88,2006-03-28,G亚宝年报,/disclosure/listedinfo/announcement/c/2006-03-28/600351_2005_n.pdf
89,2006-03-28,G亚宝监事会决议公告,/disclosure/listedinfo/announcement/c/2006-03-28/600351_20060328_2.pdf
90,2006-03-28,G亚宝关联交易公告,/disclosure/listedinfo/announcement/c/2006-03-28/600351_20060328_3.pdf
91,2006-03-28,G亚宝董事会决议公告,/disclosure/listedinfo/announcement/c/2006-03-28/600351_20060328_1.pdf
92,2006-03-28,G亚宝2005年度控股股东及其他关联方资金占用及对外担保情况的专项说明,/disclosure/listedinfo/announcement/c/2006-03-28/600351_20060328_4.pdf
93,2006-04-13,G亚宝公告,/disclosure/listedinfo/announcement/c/2006-04-13/600351_20060413_1.pdf
94,2006-04-27,G亚宝监事会决议公告,/disclosure/listedinfo/announcement/c/2006-04-27/600351_20060427_2.pdf
95,2006-04-27,G亚宝董事会决议公告暨召开2005年度股东大会的通知,/disclosure/listedinfo/announcement/c/2006-04-27/600351_20060427_1.pdf
96,2006-04-27,G亚宝第一季度季报,/disclosure/listedinfo/announcement/c/2006-04-27/600351_2006_1.pdf
97,2006-06-07,G亚宝2005年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2006-06-07/600351_20060607_1.pdf
98,2006-06-09,G亚宝监事会议事规则（2006修订）,/disclosure/listedinfo/announcement/c/2006-06-09/600351_20060609_6.pdf
99,2006-06-09,G亚宝股东大会议事规则（2006修订）,/disclosure/listedinfo/announcement/c/2006-06-09/600351_20060609_4.pdf
100,2006-06-09,G亚宝公司章程（2006修订）,/disclosure/listedinfo/announcement/c/2006-06-09/600351_20060609_g.pdf
101,2006-06-09,G亚宝董事会议事规则（2006修订）,/disclosure/listedinfo/announcement/c/2006-06-09/600351_20060609_5.pdf
102,2006-06-09,G亚宝董事会决议公告,/disclosure/listedinfo/announcement/c/2006-06-09/600351_20060609_2.pdf
103,2006-06-09,G亚宝2005年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2006-06-09/600351_20060609_1.pdf
104,2006-06-09,G亚宝2005年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2006-06-09/600351_20060609_3.pdf
105,2006-06-13,G亚宝关于联系方式变更的公告,/disclosure/listedinfo/announcement/c/2006-06-13/600351_20060613_1.pdf
106,2006-07-27,G亚宝2005年度分红派息实施公告,/disclosure/listedinfo/announcement/c/2006-07-27/600351_20060727_1.pdf
107,2006-08-09,G亚宝半年报摘要,/disclosure/listedinfo/announcement/c/2006-08-09/600351_2006_zzy.pdf
108,2006-08-09,G亚宝半年报,/disclosure/listedinfo/announcement/c/2006-08-09/600351_2006_z.pdf
109,2006-10-26,亚宝药业第三季度季报,/disclosure/listedinfo/announcement/c/2006-10-26/600351_2006_3.pdf
110,2006-12-22,亚宝药业关于企业所得税抵免的公告,/disclosure/listedinfo/announcement/c/2006-12-22/600351_20061222_1.pdf
111,2006-12-28,亚宝药业关于利息豁免的公告,/disclosure/listedinfo/announcement/c/2006-12-28/600351_20061228_1.pdf
112,2007-01-26,亚宝药业关于药品降价影响的提示性公告,/disclosure/listedinfo/announcement/c/2007-01-26/600351_20070126_1.pdf
113,2007-01-30,亚宝药业关于当选2006年度最具成长性企业的公告,/disclosure/listedinfo/announcement/c/2007-01-30/600351_20070130_1.pdf
114,2007-02-13,亚宝药业有限售条件的流通股上市公告,/disclosure/listedinfo/announcement/c/2007-02-13/600351_20070213_1.pdf
115,2007-03-13,亚宝药业年报摘要,/disclosure/listedinfo/announcement/c/2007-03-13/600351_2006_nzy.pdf
116,2007-03-13,亚宝药业年报,/disclosure/listedinfo/announcement/c/2007-03-13/600351_2006_n.pdf
117,2007-03-13,亚宝药业监事会决议公告,/disclosure/listedinfo/announcement/c/2007-03-13/600351_20070313_2.pdf
118,2007-03-13,亚宝药业关于2006年度控股股东及其他关联方资金占用及对外担保情况的专项说明,/disclosure/listedinfo/announcement/c/2007-03-13/600351_20070313_3.pdf
119,2007-03-13,亚宝药业董事会决议公告,/disclosure/listedinfo/announcement/c/2007-03-13/600351_20070313_1.pdf
120,2007-04-05,亚宝药业2007年第一季度业绩预增公告,/disclosure/listedinfo/announcement/c/2007-04-05/600351_20070405_1.pdf
121,2007-04-25,亚宝药业关于召开2006年度股东大会的通知,/disclosure/listedinfo/announcement/c/2007-04-25/600351_20070425_2.pdf
122,2007-04-25,亚宝药业董事会决议公告,/disclosure/listedinfo/announcement/c/2007-04-25/600351_20070425_1.pdf
123,2007-04-25,亚宝药业第一季度季报,/disclosure/listedinfo/announcement/c/2007-04-25/600351_2007_1.pdf
124,2007-05-17,亚宝药业关于召开2006年度股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2007-05-17/600351_20070517_1.pdf
125,2007-05-18,亚宝药业关于与九州通集团有限公司签订战略合作协议的公告,/disclosure/listedinfo/announcement/c/2007-05-18/600351_20070518_1.pdf
126,2007-05-19,亚宝药业2006年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2007-05-19/600351_20070519_1.pdf
127,2007-05-26,亚宝药业2006年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2007-05-26/600351_20070526_1.pdf
128,2007-05-26,亚宝药业2006年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2007-05-26/600351_20070526_2.pdf
129,2007-06-02,亚宝药业股票异常波动公告,/disclosure/listedinfo/announcement/c/2007-06-02/600351_20070602_1.pdf
130,2007-06-19,亚宝药业2007年中期业绩预增公告,/disclosure/listedinfo/announcement/c/2007-06-19/600351_20070619_1.pdf
131,2007-06-20,亚宝药业关于061001批次藻酸双酯钠注射液有关情况的说明公告,/disclosure/listedinfo/announcement/c/2007-06-20/600351_20070620_1.pdf
132,2007-06-29,亚宝药业信息披露制度,/disclosure/listedinfo/announcement/c/2007-06-29/600351_20070629_3.pdf
133,2007-06-29,亚宝药业关于利息豁免的公告,/disclosure/listedinfo/announcement/c/2007-06-29/600351_20070629_2.pdf
134,2007-06-29,亚宝药业董事会决议公告,/disclosure/listedinfo/announcement/c/2007-06-29/600351_20070629_1.pdf
135,2007-07-03,亚宝药业公司治理专项活动自查报告和整改计划,/disclosure/listedinfo/announcement/c/2007-07-03/600351_20070703_1.pdf
136,2007-07-13,亚宝药业2006年度分红派息实施公告,/disclosure/listedinfo/announcement/c/2007-07-13/600351_20070713_1.pdf
137,2007-07-27,亚宝药业关联交易管理制度,/disclosure/listedinfo/announcement/c/2007-07-27/600351_20070727_2.pdf
138,2007-07-27,亚宝药业董事会决议公告,/disclosure/listedinfo/announcement/c/2007-07-27/600351_20070727_1.pdf
139,2007-07-27,亚宝药业半年报摘要,/disclosure/listedinfo/announcement/c/2007-07-27/600351_2007_zzy.pdf
140,2007-07-27,亚宝药业半年报,/disclosure/listedinfo/announcement/c/2007-07-27/600351_2007_z.pdf
141,2007-08-14,亚宝药业董事会决议公告,/disclosure/listedinfo/announcement/c/2007-08-14/600351_20070814_1.pdf
142,2007-08-14,亚宝药业董事会关于前次募集资金使用情况的说明,/disclosure/listedinfo/announcement/c/2007-08-14/600351_20070814_2.pdf
143,2007-10-10,亚宝药业2007年第三季度业绩预增公告,/disclosure/listedinfo/announcement/c/2007-10-10/600351_20071010_1.pdf
144,2007-10-17,亚宝药业关于子公司变更工商登记的公告,/disclosure/listedinfo/announcement/c/2007-10-17/600351_20071017_2.pdf
145,2007-10-17,亚宝药业董事会决议公告,/disclosure/listedinfo/announcement/c/2007-10-17/600351_20071017_1.pdf
146,2007-10-17,亚宝药业第三季度季报,/disclosure/listedinfo/announcement/c/2007-10-17/600351_2007_3.pdf
147,2007-10-26,亚宝药业股票异常波动公告,/disclosure/listedinfo/announcement/c/2007-10-26/600351_20071026_1.pdf
148,2007-11-08,亚宝药业关于公司治理专项活动整改报告,/disclosure/listedinfo/announcement/c/2007-11-08/600351_20071108_2.pdf
149,2007-11-08,亚宝药业董事会决议公告,/disclosure/listedinfo/announcement/c/2007-11-08/600351_20071108_1.pdf
150,2007-12-05,亚宝药业2007年度业绩预增公告,/disclosure/listedinfo/announcement/c/2007-12-05/600351_20071205_1.pdf
151,2007-12-07,亚宝药业产品提价公告,/disclosure/listedinfo/announcement/c/2007-12-07/600351_20071207_1.pdf
152,2008-01-18,亚宝药业业绩快报,/disclosure/listedinfo/announcement/c/2008-01-18/600351_20080118_1.pdf
153,2008-01-23,亚宝药业年报摘要,/disclosure/listedinfo/announcement/c/2008-01-23/600351_2007_nzy.pdf
154,2008-01-23,亚宝药业年报,/disclosure/listedinfo/announcement/c/2008-01-23/600351_2007_n.pdf
155,2008-01-23,亚宝药业监事会决议公告,/disclosure/listedinfo/announcement/c/2008-01-23/600351_20080123_2.pdf
156,2008-01-23,亚宝药业董事会审计委员会工作细则（2008修订）,/disclosure/listedinfo/announcement/c/2008-01-23/600351_20080123_3.pdf
157,2008-01-23,亚宝药业董事会决议公告,/disclosure/listedinfo/announcement/c/2008-01-23/600351_20080123_1.pdf
158,2008-01-23,亚宝药业2007年度控股股东及其他关联方资金占用及对外担保情况的专项说明,/disclosure/listedinfo/announcement/c/2008-01-23/600351_20080123_4.pdf
159,2008-03-22,亚宝药业关于公开增发A股的申请获得中国证监会发行审核委员会审核通过的公告,/disclosure/listedinfo/announcement/c/2008-03-22/600351_20080322_1.pdf
160,2008-04-01,亚宝药业2008年第一季度业绩预增公告,/disclosure/listedinfo/announcement/c/2008-04-01/600351_20080401_1.pdf
161,2008-04-23,亚宝药业第一季度季报,/disclosure/listedinfo/announcement/c/2008-04-23/600351_2008_1.pdf
162,2008-05-06,亚宝药业关于公开增发股票的申请获中国证监会核准的公告,/disclosure/listedinfo/announcement/c/2008-05-06/600351_20080506_1.pdf
163,2008-05-13,亚宝药业增发招股意向书摘要,/disclosure/listedinfo/announcement/c/2008-05-13/600351_20080513_5.pdf
164,2008-05-13,亚宝药业增发招股意向书,/disclosure/listedinfo/announcement/c/2008-05-13/600351_20080513_4.pdf
165,2008-05-13,亚宝药业增发A股网下发行公告,/disclosure/listedinfo/announcement/c/2008-05-13/600351_20080513_2.pdf
166,2008-05-13,亚宝药业增发A股网上路演公告,/disclosure/listedinfo/announcement/c/2008-05-13/600351_20080513_3.pdf
167,2008-05-13,亚宝药业增发A股网上发行公告,/disclosure/listedinfo/announcement/c/2008-05-13/600351_20080513_1.pdf
168,2008-05-15,亚宝药业公开增发A股提示性公告,/disclosure/listedinfo/announcement/c/2008-05-15/600351_20080515_1.pdf
169,2008-05-20,亚宝药业增发A股网下发行结果及网上中签率公告,/disclosure/listedinfo/announcement/c/2008-05-20/600351_20080520_1.pdf
170,2008-05-21,亚宝药业增发A股网上资金申购发行摇号中签结果公告,/disclosure/listedinfo/announcement/c/2008-05-21/600351_20080521_1.pdf
171,2008-05-27,亚宝药业公开增发A股上市公告书,/disclosure/listedinfo/announcement/c/2008-05-27/600351_20080527_1.pdf
172,2008-06-04,亚宝药业监事会决议公告,/disclosure/listedinfo/announcement/c/2008-06-04/600351_20080604_2.pdf
173,2008-06-04,亚宝药业董事会决议公告暨召开2007年度股东大会的通知,/disclosure/listedinfo/announcement/c/2008-06-04/600351_20080604_1.pdf
174,2008-06-11,亚宝药业2008年中期业绩预增公告,/disclosure/listedinfo/announcement/c/2008-06-11/600351_20080611_1.pdf
175,2008-06-21,亚宝药业2007年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2008-06-21/600351_20080621_1.pdf
176,2008-06-27,亚宝药业监事会决议公告,/disclosure/listedinfo/announcement/c/2008-06-27/600351_20080627_3.pdf
177,2008-06-27,亚宝药业关于使用部分闲置募集资金暂时补充流动资金的公告,/disclosure/listedinfo/announcement/c/2008-06-27/600351_20080627_4.pdf
178,2008-06-27,亚宝药业董事会决议公告,/disclosure/listedinfo/announcement/c/2008-06-27/600351_20080627_2.pdf
179,2008-06-27,亚宝药业2007年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2008-06-27/600351_20080627_1.pdf
180,2008-06-27,亚宝药业2007年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2008-06-27/600351_20080627_5.pdf
181,2008-07-02,亚宝药业2008年中期业绩预增修正公告,/disclosure/listedinfo/announcement/c/2008-07-02/600351_20080702_1.pdf
182,2008-07-08,亚宝药业公司章程（2008修订）,/disclosure/listedinfo/announcement/c/2008-07-08/600351_20080708_g.pdf
183,2008-07-08,亚宝药业独立董事工作制度（2008修订）,/disclosure/listedinfo/announcement/c/2008-07-08/600351_20080708_1.pdf
184,2008-08-01,亚宝药业关于公司治理专项活动整改情况的说明,/disclosure/listedinfo/announcement/c/2008-08-01/600351_20080801_3.pdf
185,2008-08-01,亚宝药业第四届监事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2008-08-01/600351_20080801_2.pdf
186,2008-08-01,亚宝药业第四届董事会第二次会议决议公告暨召开2008年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2008-08-01/600351_20080801_1.pdf
187,2008-08-01,亚宝药业半年报摘要,/disclosure/listedinfo/announcement/c/2008-08-01/600351_2008_zzy.pdf
188,2008-08-01,亚宝药业半年报,/disclosure/listedinfo/announcement/c/2008-08-01/600351_2008_z.pdf
189,2008-08-16,亚宝药业2008年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2008-08-16/600351_20080816_1.pdf
190,2008-08-20,亚宝药业2008年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2008-08-20/600351_20080820_1.pdf
191,2008-08-20,亚宝药业2008年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2008-08-20/600351_20080820_2.pdf
192,2008-09-04,亚宝药业有限售条件的流通股上市流通公告,/disclosure/listedinfo/announcement/c/2008-09-04/600351_20080904_1.pdf
193,2008-09-10,亚宝药业控股股东承诺公告,/disclosure/listedinfo/announcement/c/2008-09-10/600351_20080910_1.pdf
194,2008-10-07,亚宝药业2008年第三季度业绩预增公告,/disclosure/listedinfo/announcement/c/2008-10-07/600351_20081007_1.pdf
195,2008-10-11,亚宝药业重要事项公告,/disclosure/listedinfo/announcement/c/2008-10-11/600351_20081011_1.pdf
196,2008-10-24,亚宝药业为山西亚宝新龙药业有限公司提供担保的公告,/disclosure/listedinfo/announcement/c/2008-10-24/600351_20081024_2.pdf
197,2008-10-24,亚宝药业第四届董事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2008-10-24/600351_20081024_1.pdf
198,2008-10-24,亚宝药业第三季度季报,/disclosure/listedinfo/announcement/c/2008-10-24/600351_2008_3.pdf
199,2008-11-18,亚宝药业关于公司技术中心获国家认定企业技术中心的公告,/disclosure/listedinfo/announcement/c/2008-11-18/600351_20081118_1.pdf
200,2008-12-13,亚宝药业关于公司被认定为高新技术企业的公告,/disclosure/listedinfo/announcement/c/2008-12-13/600351_20081213_1.pdf
201,2008-12-23,亚宝药业关于控股子公司四川亚宝光泰药业有限公司搬迁的公告,/disclosure/listedinfo/announcement/c/2008-12-23/600351_20081223_2.pdf
202,2008-12-23,亚宝药业关于控股股东股权质押的公告,/disclosure/listedinfo/announcement/c/2008-12-23/600351_20081223_1.pdf
203,2009-01-15,亚宝药业2008年度业绩预增公告,/disclosure/listedinfo/announcement/c/2009-01-15/600351_20090115_1.pdf
204,2009-01-16,亚宝药业重大事项公告,/disclosure/listedinfo/announcement/c/2009-01-16/600351_20090116_1.pdf
205,2009-02-07,亚宝药业股东股份减持公告,/disclosure/listedinfo/announcement/c/2009-02-07/600351_20090207_1.pdf
206,2009-02-11,亚宝药业有限售条件的流通股上市流通的公告,/disclosure/listedinfo/announcement/c/2009-02-11/600351_20090211_1.pdf
207,2009-02-20,亚宝药业关于流动资金归还募集资金的公告,/disclosure/listedinfo/announcement/c/2009-02-20/600351_20090220_1.pdf
208,2009-02-24,亚宝药业重大事项公告,/disclosure/listedinfo/announcement/c/2009-02-24/600351_20090224_1.pdf
209,2009-03-05,亚宝药业年报摘要,/disclosure/listedinfo/announcement/c/2009-03-05/600351_2008_nzy.pdf
210,2009-03-05,亚宝药业年报,/disclosure/listedinfo/announcement/c/2009-03-05/600351_2008_n.pdf
211,2009-03-05,亚宝药业关于收购亚宝药业太原制药有限公司部分股权的关联交易公告,/disclosure/listedinfo/announcement/c/2009-03-05/600351_20090305_5.pdf
212,2009-03-05,亚宝药业关于收购山西亚宝医药经销有限公司部分股权的的关联交易公告,/disclosure/listedinfo/announcement/c/2009-03-05/600351_20090305_7.pdf
213,2009-03-05,亚宝药业关于收购北京亚宝国际贸易有限公司部分股权的关联交易公告,/disclosure/listedinfo/announcement/c/2009-03-05/600351_20090305_4.pdf
214,2009-03-05,亚宝药业关于公司2008年度前期会计差错更正说明的公告,/disclosure/listedinfo/announcement/c/2009-03-05/600351_20090305_3.pdf
215,2009-03-05,亚宝药业关于调整部分募集资金项目投资金额的公告,/disclosure/listedinfo/announcement/c/2009-03-05/600351_20090305_6.pdf
216,2009-03-05,亚宝药业第四届监事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2009-03-05/600351_20090305_2.pdf
217,2009-03-05,亚宝药业第四届董事会第四次会议决议公告暨召开2008年度股东大会的通知,/disclosure/listedinfo/announcement/c/2009-03-05/600351_20090305_1.pdf
218,2009-03-05,亚宝药业2008年度控股股东及其他关联方资金占用及对外担保情况的专项说明,/disclosure/listedinfo/announcement/c/2009-03-05/600351_20090305_8.pdf
219,2009-03-17,亚宝药业关于召开2008年度股东大会的二次通知,/disclosure/listedinfo/announcement/c/2009-03-17/600351_20090317_1.pdf
220,2009-03-19,亚宝药业2008年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2009-03-19/600351_20090319_1.pdf
221,2009-03-26,亚宝药业2008年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2009-03-26/600351_20090326_1.pdf
222,2009-03-26,亚宝药业2008年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2009-03-26/600351_20090326_2.pdf
223,2009-03-27,亚宝药业公司章程（2009修订）,/disclosure/listedinfo/announcement/c/2009-03-27/600351_20090327_g.pdf
224,2009-04-09,亚宝药业2009年第一季度业绩预增公告,/disclosure/listedinfo/announcement/c/2009-04-09/600351_20090409_1.pdf
225,2009-04-14,亚宝药业2008年利润分配及公积金转增股本实施公告,/disclosure/listedinfo/announcement/c/2009-04-14/600351_20090414_1.pdf
226,2009-04-22,亚宝药业第一季度季报,/disclosure/listedinfo/announcement/c/2009-04-22/600351_2009_1.pdf
227,2009-04-22,亚宝药业第四届董事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2009-04-22/600351_20090422_1.pdf
228,2009-05-06,亚宝药业关于变更公司名称的公告,/disclosure/listedinfo/announcement/c/2009-05-06/600351_20090506_1.pdf
229,2009-05-14,亚宝药业公司章程（2009修订）,/disclosure/listedinfo/announcement/c/2009-05-14/600351_20090514_g.pdf
230,2009-05-19,亚宝药业关于举行2008年年度报告业绩说明会的公告,/disclosure/listedinfo/announcement/c/2009-05-19/600351_20090519_1.pdf
231,2009-06-18,亚宝药业重大事项进展公告,/disclosure/listedinfo/announcement/c/2009-06-18/600351_20090618_1.pdf
232,2009-06-24,亚宝药业2009年中期业绩预增公告,/disclosure/listedinfo/announcement/c/2009-06-24/600351_20090624_1.pdf
233,2009-06-30,亚宝药业关于控股股东部分股权质押的公告,/disclosure/listedinfo/announcement/c/2009-06-30/600351_20090630_1.pdf
234,2009-07-31,亚宝药业第四届董事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2009-07-31/600351_20090731_1.pdf
235,2009-07-31,亚宝药业半年报摘要,/disclosure/listedinfo/announcement/c/2009-07-31/600351_2009_zzy.pdf
236,2009-07-31,亚宝药业半年报,/disclosure/listedinfo/announcement/c/2009-07-31/600351_2009_z.pdf
237,2009-08-07,亚宝药业股东减持公告,/disclosure/listedinfo/announcement/c/2009-08-07/600351_20090807_1.pdf
238,2009-08-08,亚宝药业简式权益变动报告书,/disclosure/listedinfo/announcement/c/2009-08-08/600351_20090808_1.pdf
239,2009-08-11,亚宝药业半年报摘要（修订版）,/disclosure/listedinfo/announcement/c/2009-08-11/600351_2009_zzy.pdf
240,2009-08-11,亚宝药业半年报（修订版）,/disclosure/listedinfo/announcement/c/2009-08-11/600351_2009_z.pdf
241,2009-08-11,亚宝药业2009年半年度报告更正公告,/disclosure/listedinfo/announcement/c/2009-08-11/600351_20090811_1.pdf
242,2009-08-29,亚宝药业关于公司及下属子公司产品进入《国家基本药物目录》的提示性公告,/disclosure/listedinfo/announcement/c/2009-08-29/600351_20090829_1.pdf
243,2009-09-01,亚宝药业股东减持公告,/disclosure/listedinfo/announcement/c/2009-09-01/600351_20090901_1.pdf
244,2009-09-08,亚宝药业股东减持公告,/disclosure/listedinfo/announcement/c/2009-09-08/600351_20090908_1.pdf
245,2009-10-13,亚宝药业2009年第三季度业绩预增公告,/disclosure/listedinfo/announcement/c/2009-10-13/600351_20091013_1.pdf
246,2009-10-28,亚宝药业第三季度季报,/disclosure/listedinfo/announcement/c/2009-10-28/600351_2009_3.pdf
247,2009-11-05,亚宝药业简式权益变动报告书,/disclosure/listedinfo/announcement/c/2009-11-05/600351_20091105_1.pdf
248,2009-11-11,亚宝药业关于公司专利产品忍冬感冒颗粒对甲型H1N1流感病毒有明显治疗作用的公告,/disclosure/listedinfo/announcement/c/2009-11-11/600351_20091111_1.pdf
249,2009-11-13,亚宝药业关于相关媒体报道的澄清公告,/disclosure/listedinfo/announcement/c/2009-11-13/600351_20091113_1.pdf
250,2009-12-16,亚宝药业关于会计师事务所更名公告,/disclosure/listedinfo/announcement/c/2009-12-16/600351_20091216_1.pdf
251,2010-01-05,亚宝药业关于全资子公司名称变更的公告,/disclosure/listedinfo/announcement/c/2010-01-05/600351_20100105_3.pdf
252,2010-01-05,亚宝药业关于获得国家补助资金的公告,/disclosure/listedinfo/announcement/c/2010-01-05/600351_20100105_2.pdf
253,2010-01-05,亚宝药业2009年度业绩预增公告,/disclosure/listedinfo/announcement/c/2010-01-05/600351_20100105_1.pdf
254,2010-01-13,亚宝药业第四届董事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2010-01-13/600351_20100113_1.pdf
255,2010-03-05,亚宝药业重大事项内部报告制度,/disclosure/listedinfo/announcement/c/2010-03-05/600351_20100305_6.pdf
256,2010-03-05,亚宝药业年报摘要,/disclosure/listedinfo/announcement/c/2010-03-05/600351_2009_nzy.pdf
257,2010-03-05,亚宝药业年报信息披露重大差错责任追究制度,/disclosure/listedinfo/announcement/c/2010-03-05/600351_20100305_10.pdf
258,2010-03-05,亚宝药业年报,/disclosure/listedinfo/announcement/c/2010-03-05/600351_2009_n.pdf
259,2010-03-05,亚宝药业内幕信息知情人登记制度,/disclosure/listedinfo/announcement/c/2010-03-05/600351_20100305_9.pdf
260,2010-03-05,亚宝药业控股股东及其他关联方资金占用情况的专项说明,/disclosure/listedinfo/announcement/c/2010-03-05/600351_20100305_5.pdf
261,2010-03-05,亚宝药业关于中国证监会山西证监局现场检查提出问题的整改报告,/disclosure/listedinfo/announcement/c/2010-03-05/600351_20100305_4.pdf
262,2010-03-05,亚宝药业关于公司募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2010-03-05/600351_20100305_3.pdf
263,2010-03-05,亚宝药业对外信息报送和使用管理办法,/disclosure/listedinfo/announcement/c/2010-03-05/600351_20100305_11.pdf
264,2010-03-05,亚宝药业董事会战略委员会工作细则,/disclosure/listedinfo/announcement/c/2010-03-05/600351_20100305_12.pdf
265,2010-03-05,亚宝药业董事会薪酬与考核委员会工作细则,/disclosure/listedinfo/announcement/c/2010-03-05/600351_20100305_13.pdf
266,2010-03-05,亚宝药业董事会提名委员会工作细则,/disclosure/listedinfo/announcement/c/2010-03-05/600351_20100305_8.pdf
267,2010-03-05,亚宝药业董事会审计委员会工作细则,/disclosure/listedinfo/announcement/c/2010-03-05/600351_20100305_7.pdf
268,2010-03-05,亚宝药业第四届监事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2010-03-05/600351_20100305_2.pdf
269,2010-03-05,亚宝药业第四届董事会第九次会议决议公告,/disclosure/listedinfo/announcement/c/2010-03-05/600351_20100305_1.pdf
270,2010-03-12,亚宝药业关于控股子公司亚宝药业大同制药有限公司变更为全资子公司的公告,/disclosure/listedinfo/announcement/c/2010-03-12/600351_20100312_2.pdf
271,2010-03-12,亚宝药业关于控股股东名称变更的公告,/disclosure/listedinfo/announcement/c/2010-03-12/600351_20100312_1.pdf
272,2010-03-30,亚宝药业2010年第一季度业绩预增公告,/disclosure/listedinfo/announcement/c/2010-03-30/600351_20100330_1.pdf
273,2010-04-02,亚宝药业关于竞买北京中医药大学药厂70%产权的进展公告,/disclosure/listedinfo/announcement/c/2010-04-02/600351_20100402_1.pdf
274,2010-04-15,亚宝药业年报（修订版）,/disclosure/listedinfo/announcement/c/2010-04-15/600351_2009_n.pdf
275,2010-04-15,亚宝药业关于竞买北京中医药大学药厂70%产权成功的公告,/disclosure/listedinfo/announcement/c/2010-04-15/600351_20100415_6.pdf
276,2010-04-15,亚宝药业关于出让股权的公告,/disclosure/listedinfo/announcement/c/2010-04-15/600351_20100415_3.pdf
277,2010-04-15,亚宝药业关于补充披露2009年年度报告中财务报告相关信息的公告,/disclosure/listedinfo/announcement/c/2010-04-15/600351_20100415_5.pdf
278,2010-04-15,亚宝药业关于变更募集资金投资项目的公告,/disclosure/listedinfo/announcement/c/2010-04-15/600351_20100415_4.pdf
279,2010-04-15,亚宝药业第一季度季报,/disclosure/listedinfo/announcement/c/2010-04-15/600351_2010_1.pdf
280,2010-04-15,亚宝药业第四届监事会第九次会议决议公告,/disclosure/listedinfo/announcement/c/2010-04-15/600351_20100415_2.pdf
281,2010-04-15,亚宝药业第四届董事会第十次会议决议公告暨召开2009年度股东大会的通知,/disclosure/listedinfo/announcement/c/2010-04-15/600351_20100415_1.pdf
282,2010-04-29,亚宝药业关于控股股东股权质押解除的公告,/disclosure/listedinfo/announcement/c/2010-04-29/600351_20100429_1.pdf
283,2010-05-05,亚宝药业关于召开2009年度股东大会的二次通知,/disclosure/listedinfo/announcement/c/2010-05-05/600351_20100505_1.pdf
284,2010-05-05,亚宝药业2009年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-05-05/600351_20100505_2.pdf
285,2010-05-12,亚宝药业股东大会议事规则,/disclosure/listedinfo/announcement/c/2010-05-12/600351_20100512_3.pdf
286,2010-05-12,亚宝药业公司章程（2010修订）,/disclosure/listedinfo/announcement/c/2010-05-12/600351_20100512_g.pdf
287,2010-05-12,亚宝药业2009年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2010-05-12/600351_20100512_1.pdf
288,2010-05-12,亚宝药业2009年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2010-05-12/600351_20100512_2.pdf
289,2010-05-18,亚宝药业关于举行2009年年度报告业绩说明会的公告,/disclosure/listedinfo/announcement/c/2010-05-18/600351_20100518_1.pdf
290,2010-05-24,亚宝药业2009年度利润分配及公积金转增股本实施公告,/disclosure/listedinfo/announcement/c/2010-05-24/600351_20100524_1.pdf
291,2010-07-10,亚宝药业重大事项进展公告,/disclosure/listedinfo/announcement/c/2010-07-10/600351_20100710_1.pdf
292,2010-08-06,亚宝药业半年报摘要,/disclosure/listedinfo/announcement/c/2010-08-06/600351_2010_zzy.pdf
293,2010-08-06,亚宝药业半年报,/disclosure/listedinfo/announcement/c/2010-08-06/600351_2010_z.pdf
294,2010-10-26,亚宝药业关联交易公告,/disclosure/listedinfo/announcement/c/2010-10-26/600351_20101026_2.pdf
295,2010-10-26,亚宝药业第四届董事会第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2010-10-26/600351_20101026_1.pdf
296,2010-10-26,亚宝药业第三季度季报,/disclosure/listedinfo/announcement/c/2010-10-26/600351_2010_3.pdf
297,2010-12-08,亚宝药业第四届董事会第十三次会议决议公告,/disclosure/listedinfo/announcement/c/2010-12-08/600351_20101208_1.pdf
298,2011-02-23,亚宝药业年报摘要,/disclosure/listedinfo/announcement/c/2011-02-23/600351_2010_nzy.pdf
299,2011-02-23,亚宝药业年报,/disclosure/listedinfo/announcement/c/2011-02-23/600351_2010_n.pdf
300,2011-02-23,亚宝药业控股股东及其他关联方资金占用情况的专项说明,/disclosure/listedinfo/announcement/c/2011-02-23/600351_20110223_4.pdf
301,2011-02-23,亚宝药业关于公司募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2011-02-23/600351_20110223_3.pdf
302,2011-02-23,亚宝药业第四届监事会第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2011-02-23/600351_20110223_2.pdf
303,2011-02-23,亚宝药业第四届董事会第十四次会议决议公告,/disclosure/listedinfo/announcement/c/2011-02-23/600351_20110223_1.pdf
304,2011-02-23,亚宝药业2010年度社会责任报告,/disclosure/listedinfo/announcement/c/2011-02-23/600351_20110223_6.pdf
305,2011-02-23,亚宝药业2010年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2011-02-23/600351_20110223_5.pdf
306,2011-03-02,亚宝药业2010年持续督导年度报告书,/disclosure/listedinfo/announcement/c/2011-03-02/600351_20110302_1.pdf
307,2011-04-01,亚宝药业内部控制规范实施工作方案,/disclosure/listedinfo/announcement/c/2011-04-01/600351_20110401_2.pdf
308,2011-04-01,亚宝药业第四届董事会第十五次会议决议公告,/disclosure/listedinfo/announcement/c/2011-04-01/600351_20110401_1.pdf
309,2011-04-22,亚宝药业第一季度季报,/disclosure/listedinfo/announcement/c/2011-04-22/600351_2011_1.pdf
310,2011-04-22,亚宝药业第四届董事会第十六次会议决议公告暨召开公司2010年度股东大会的通知,/disclosure/listedinfo/announcement/c/2011-04-22/600351_20110422_1.pdf
311,2011-05-06,亚宝药业关于举行2010年年度业绩说明会的公告,/disclosure/listedinfo/announcement/c/2011-05-06/600351_20110506_1.pdf
312,2011-05-13,亚宝药业关于2010年度股东大会增加临时议案的公告,/disclosure/listedinfo/announcement/c/2011-05-13/600351_20110513_3.pdf
313,2011-05-13,亚宝药业董事会秘书工作制度,/disclosure/listedinfo/announcement/c/2011-05-13/600351_20110513_4.pdf
314,2011-05-13,亚宝药业第四届监事会第十四次会议决议公告,/disclosure/listedinfo/announcement/c/2011-05-13/600351_20110513_2.pdf
315,2011-05-13,亚宝药业第四届董事会第十七次会议决议公告,/disclosure/listedinfo/announcement/c/2011-05-13/600351_20110513_1.pdf
316,2011-05-31,亚宝药业重大事项公告,/disclosure/listedinfo/announcement/c/2011-05-31/600351_20110531_1.pdf
317,2011-06-16,亚宝药业2010年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2011-06-16/600351_20110616_1.pdf
318,2011-06-24,亚宝药业关于全资子公司通过GMP认证的公告,/disclosure/listedinfo/announcement/c/2011-06-24/600351_20110624_4.pdf
319,2011-06-24,亚宝药业第五届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2011-06-24/600351_20110624_3.pdf
320,2011-06-24,亚宝药业第五届董事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2011-06-24/600351_20110624_2.pdf
321,2011-06-24,亚宝药业2010年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2011-06-24/600351_20110624_1.pdf
322,2011-06-24,亚宝药业2010年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2011-06-24/600351_20110624_5.pdf
323,2011-07-05,亚宝药业2011年中期业绩预减公告,/disclosure/listedinfo/announcement/c/2011-07-05/600351_20110705_1.pdf
324,2011-07-12,亚宝药业2010年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2011-07-12/600351_20110712_1.pdf
325,2011-08-19,亚宝药业关于公司募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2011-08-19/600351_20110819_3.pdf
326,2011-08-19,亚宝药业第五届监事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2011-08-19/600351_20110819_2.pdf
327,2011-08-19,亚宝药业第五届董事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2011-08-19/600351_20110819_1.pdf
328,2011-08-19,亚宝药业半年报摘要,/disclosure/listedinfo/announcement/c/2011-08-19/600351_2011_zzy.pdf
329,2011-08-19,亚宝药业半年报,/disclosure/listedinfo/announcement/c/2011-08-19/600351_2011_z.pdf
330,2011-10-17,亚宝药业重大事项停牌公告,/disclosure/listedinfo/announcement/c/2011-10-17/600351_20111017_1.pdf
331,2011-10-24,亚宝药业延期复牌的公告,/disclosure/listedinfo/announcement/c/2011-10-24/600351_20111024_1.pdf
332,2011-10-26,亚宝药业第五届董事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2011-10-26/600351_20111026_1.pdf
333,2011-10-26,亚宝药业第三季度季报,/disclosure/listedinfo/announcement/c/2011-10-26/600351_2011_3.pdf
334,2011-10-31,亚宝药业重大事项进展公告,/disclosure/listedinfo/announcement/c/2011-10-31/600351_20111031_1.pdf
335,2011-11-07,亚宝药业关于关联方认购非公开发行股票涉及的关联交易公告,/disclosure/listedinfo/announcement/c/2011-11-07/600351_20111107_2.pdf
336,2011-11-07,亚宝药业非公开发行股票预案,/disclosure/listedinfo/announcement/c/2011-11-07/600351_20111107_3.pdf
337,2011-11-07,亚宝药业第五届董事会第四次会议决议公告暨召开公司2011年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2011-11-07/600351_20111107_1.pdf
338,2011-11-15,亚宝药业关于召开2011年第一次临时股东大会的二次通知,/disclosure/listedinfo/announcement/c/2011-11-15/600351_20111115_1.pdf
339,2011-11-15,亚宝药业2011年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2011-11-15/600351_20111115_2.pdf
340,2011-11-23,亚宝药业2011年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2011-11-23/600351_20111123_1.pdf
341,2011-11-23,亚宝药业2011年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2011-11-23/600351_20111123_2.pdf
342,2011-12-21,亚宝药业重大事项公告,/disclosure/listedinfo/announcement/c/2011-12-21/600351_20111221_1.pdf
343,2012-02-04,亚宝药业年报摘要,/disclosure/listedinfo/announcement/c/2012-02-04/600351_2011_nzy.pdf
344,2012-02-04,亚宝药业年报,/disclosure/listedinfo/announcement/c/2012-02-04/600351_2011_n.pdf
345,2012-02-04,亚宝药业控股股东及其他关联方资金占用情况的专项说明,/disclosure/listedinfo/announcement/c/2012-02-04/600351_20120204_4.pdf
346,2012-02-04,亚宝药业关于公司募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2012-02-04/600351_20120204_3.pdf
347,2012-02-04,亚宝药业第五届监事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2012-02-04/600351_20120204_2.pdf
348,2012-02-04,亚宝药业第五届董事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2012-02-04/600351_20120204_1.pdf
349,2012-02-04,亚宝药业2011年度社会责任报告,/disclosure/listedinfo/announcement/c/2012-02-04/600351_20120204_8.pdf
350,2012-02-04,亚宝药业2011年度内部控制审计报告,/disclosure/listedinfo/announcement/c/2012-02-04/600351_20120204_6.pdf
351,2012-02-04,亚宝药业2011年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2012-02-04/600351_20120204_7.pdf
352,2012-02-04,亚宝药业2011年度独立董事述职报告,/disclosure/listedinfo/announcement/c/2012-02-04/600351_20120204_5.pdf
353,2012-04-24,亚宝药业第一季度季报,/disclosure/listedinfo/announcement/c/2012-04-24/600351_2012_1.pdf
354,2012-04-24,亚宝药业第五届董事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2012-04-24/600351_20120424_1.pdf
355,2012-05-29,亚宝药业关于举行2011年度业绩网上说明会的公告,/disclosure/listedinfo/announcement/c/2012-05-29/600351_20120529_1.pdf
356,2012-06-05,亚宝药业关于召开公司2011年度股东大会的通知,/disclosure/listedinfo/announcement/c/2012-06-05/600351_20120605_1.pdf
357,2012-06-16,亚宝药业关于非公开发行股票获得中国证监会发审委审核通过的公告,/disclosure/listedinfo/announcement/c/2012-06-16/600351_20120616_1.pdf
358,2012-06-21,亚宝药业2011年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2012-06-21/600351_20120621_1.pdf
359,2012-06-29,亚宝药业关于变更坏帐准备计提比例的公告,/disclosure/listedinfo/announcement/c/2012-06-29/600351_20120629_4.pdf
360,2012-06-29,亚宝药业分红政策及未来三年股东回报规划（2012-2014年）,/disclosure/listedinfo/announcement/c/2012-06-29/600351_20120629_6.pdf
361,2012-06-29,亚宝药业第五届监事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2012-06-29/600351_20120629_3.pdf
362,2012-06-29,亚宝药业第五届董事会第七次会议决议公告暨召开公司2012年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2012-06-29/600351_20120629_2.pdf
363,2012-06-29,亚宝药业2011年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-06-29/600351_20120629_1.pdf
364,2012-06-29,亚宝药业2011年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2012-06-29/600351_20120629_5.pdf
365,2012-07-10,亚宝药业2012年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2012-07-10/600351_20120710_1.pdf
366,2012-07-18,亚宝药业公司章程（2012修订）,/disclosure/listedinfo/announcement/c/2012-07-18/600351_20120718_g.pdf
367,2012-07-18,亚宝药业2012年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-07-18/600351_20120718_1.pdf
368,2012-07-18,亚宝药业2012年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2012-07-18/600351_20120718_2.pdf
369,2012-07-26,亚宝药业关于非公开发行股票预案中利润分配政策的补充公告,/disclosure/listedinfo/announcement/c/2012-07-26/600351_20120726_1.pdf
370,2012-08-11,亚宝药业半年报摘要,/disclosure/listedinfo/announcement/c/2012-08-11/600351_2012_zzy.pdf
371,2012-08-11,亚宝药业半年报,/disclosure/listedinfo/announcement/c/2012-08-11/600351_2012_z.pdf
372,2012-09-05,亚宝药业关于收到中国证券监督管理委员会核准非公开发行股票批文的公告,/disclosure/listedinfo/announcement/c/2012-09-05/600351_20120905_1.pdf
373,2012-09-13,亚宝药业关于控股股东股权质押的公告,/disclosure/listedinfo/announcement/c/2012-09-13/600351_20120913_1.pdf
374,2012-10-17,亚宝药业非公开发行股票发行情况报告书,/disclosure/listedinfo/announcement/c/2012-10-17/600351_20121017_2.pdf
375,2012-10-17,亚宝药业非公开发行股票发行结果暨股份变动公告,/disclosure/listedinfo/announcement/c/2012-10-17/600351_20121017_1.pdf
376,2012-10-20,亚宝药业关于签订募集资金专户存储三方监管协议的公告,/disclosure/listedinfo/announcement/c/2012-10-20/600351_20121020_1.pdf
377,2012-10-31,亚宝药业关于改聘会计师事务所的公告,/disclosure/listedinfo/announcement/c/2012-10-31/600351_20121031_3.pdf
378,2012-10-31,亚宝药业关于调减募集资金投资项目的公告,/disclosure/listedinfo/announcement/c/2012-10-31/600351_20121031_2.pdf
379,2012-10-31,亚宝药业公司章程（2012修订）,/disclosure/listedinfo/announcement/c/2012-10-31/600351_20121031_g.pdf
380,2012-10-31,亚宝药业第五届监事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2012-10-31/600351_20121031_4.pdf
381,2012-10-31,亚宝药业第五届董事会第九次会议决议公告暨召开公司2012年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2012-10-31/600351_20121031_1.pdf
382,2012-10-31,亚宝药业第三季度季报,/disclosure/listedinfo/announcement/c/2012-10-31/600351_2012_3.pdf
383,2012-11-13,亚宝药业2012年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2012-11-13/600351_20121113_1.pdf
384,2012-11-21,亚宝药业2012年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-11-21/600351_20121121_1.pdf
385,2012-11-21,亚宝药业2012年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2012-11-21/600351_20121121_2.pdf
386,2012-12-11,亚宝药业内幕信息知情人登记制度,/disclosure/listedinfo/announcement/c/2012-12-11/600351_20121211_3.pdf
387,2012-12-11,亚宝药业内部控制评价管理制度,/disclosure/listedinfo/announcement/c/2012-12-11/600351_20121211_4.pdf
388,2012-12-11,亚宝药业关于山西证监局现场检查发现问题的整改报告,/disclosure/listedinfo/announcement/c/2012-12-11/600351_20121211_2.pdf
389,2012-12-11,亚宝药业第五届董事会第十次会议决议公告,/disclosure/listedinfo/announcement/c/2012-12-11/600351_20121211_1.pdf
390,2012-12-21,亚宝药业关于控股股东股权质押的公告,/disclosure/listedinfo/announcement/c/2012-12-21/600351_20121221_1.pdf
391,2013-01-29,亚宝药业2012年年度业绩预减公告,/disclosure/listedinfo/announcement/c/2013-01-28/600351_20130129_1.pdf
392,2013-02-07,亚宝药业详式权益变动报告书之财务顾问核查意见,/disclosure/listedinfo/announcement/c/2013-02-06/600351_20130207_3.pdf
393,2013-02-07,亚宝药业详式权益变动报告书,/disclosure/listedinfo/announcement/c/2013-02-06/600351_20130207_2.pdf
394,2013-02-07,亚宝药业关于控股股东股权结构变化的提示性公告,/disclosure/listedinfo/announcement/c/2013-02-06/600351_20130207_1.pdf
395,2013-02-26,亚宝药业关于以募集资金置换预先投入募投项目自筹资金的公告,/disclosure/listedinfo/announcement/c/2013-02-25/600351_20130226_3.pdf
396,2013-02-26,亚宝药业第五届监事会第九次会议决议公告,/disclosure/listedinfo/announcement/c/2013-02-25/600351_20130226_2.pdf
397,2013-02-26,亚宝药业第五届董事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2013-02-25/600351_20130226_1.pdf
398,2013-04-26,亚宝药业年报摘要,/disclosure/listedinfo/announcement/c/2013-04-25/600351_2012_nzy.pdf
399,2013-04-26,亚宝药业年报,/disclosure/listedinfo/announcement/c/2013-04-25/600351_2012_n.pdf
400,2013-04-26,亚宝药业关于召开2012年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2013-04-25/600351_20130426_7.pdf
401,2013-04-26,亚宝药业关于变更募集资金投资项目的公告,/disclosure/listedinfo/announcement/c/2013-04-25/600351_20130426_6.pdf
402,2013-04-26,亚宝药业非经营性资金占用及其他关联资金往来的专项说明,/disclosure/listedinfo/announcement/c/2013-04-25/600351_20130426_16.pdf
403,2013-04-26,亚宝药业对外担保情况的专项说明和独立意见,/disclosure/listedinfo/announcement/c/2013-04-25/600351_20130426_14.pdf
404,2013-04-26,亚宝药业董事、高级管理人员关于公司2012年年度报告的书面确认意见,/disclosure/listedinfo/announcement/c/2013-04-25/600351_20130426_17.pdf
405,2013-04-26,亚宝药业第一季度季报,/disclosure/listedinfo/announcement/c/2013-04-25/600351_2013_1.pdf
406,2013-04-26,亚宝药业第五届监事会第十次会议决议公告,/disclosure/listedinfo/announcement/c/2013-04-25/600351_20130426_4.pdf
407,2013-04-26,亚宝药业第五届董事会第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2013-04-25/600351_20130426_3.pdf
408,2013-04-26,亚宝药业变更募集资金投资项目的专项核查意见,/disclosure/listedinfo/announcement/c/2013-04-25/600351_20130426_12.pdf
409,2013-04-26,亚宝药业2012年度审计报告,/disclosure/listedinfo/announcement/c/2013-04-25/600351_20130426_18.pdf
410,2013-04-26,亚宝药业2012年度社会责任报告,/disclosure/listedinfo/announcement/c/2013-04-25/600351_20130426_23.pdf
411,2013-04-26,亚宝药业2012年度内部控制自我评价报告,/disclosure/listedinfo/announcement/c/2013-04-25/600351_20130426_19.pdf
412,2013-04-26,亚宝药业2012年度内部控制审计报告,/disclosure/listedinfo/announcement/c/2013-04-25/600351_20130426_20.pdf
413,2013-04-26,亚宝药业2012年度募集资金存放与使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2013-04-25/600351_20130426_10.pdf
414,2013-04-26,亚宝药业2012年度募集资金存放与使用情况的专项核查意见,/disclosure/listedinfo/announcement/c/2013-04-25/600351_20130426_11.pdf
415,2013-04-26,亚宝药业2012年度募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2013-04-25/600351_20130426_5.pdf
416,2013-04-26,亚宝药业2012年度会计估计变更的专项说明,/disclosure/listedinfo/announcement/c/2013-04-25/600351_20130426_21.pdf
417,2013-04-26,亚宝药业2012年度独立董事述职报告,/disclosure/listedinfo/announcement/c/2013-04-25/600351_20130426_15.pdf
418,2013-04-26,亚宝药业2012年持续督导年度报告书,/disclosure/listedinfo/announcement/c/2013-04-25/600351_20130426_22.pdf
419,2013-05-09,亚宝药业2012年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2013-05-08/600351_20130509_1.pdf
420,2013-05-17,亚宝药业2012年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2013-05-16/600351_20130517_1.pdf
421,2013-05-17,亚宝药业2012年度股东大会律师见证法律意见书,/disclosure/listedinfo/announcement/c/2013-05-16/600351_20130517_2.pdf
422,2013-06-01,亚宝药业关于举行2012年度业绩网上说明会的公告,/disclosure/listedinfo/announcement/c/2013-05-31/600351_20130601_1.pdf
423,2013-06-19,亚宝药业2012年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2013-06-18/600351_20130619_2.pdf
424,2013-06-29,亚宝药业关于控股股东股权质押解除的公告,/disclosure/listedinfo/announcement/c/2013-06-28/600351_20130629_1.pdf
425,2013-07-06,亚宝药业关于控股股东股权质押的公告,/disclosure/listedinfo/announcement/c/2013-07-05/600351_20130706_1.pdf
426,2013-08-27,亚宝药业第五届监事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2013-08-26/600351_20130827_3.pdf
427,2013-08-27,亚宝药业第五届董事会第十三次会议决议公告,/disclosure/listedinfo/announcement/c/2013-08-26/600351_20130827_2.pdf
428,2013-08-27,亚宝药业半年报摘要,/disclosure/listedinfo/announcement/c/2013-08-26/600351_2013_zzy.pdf
429,2013-08-27,亚宝药业半年报,/disclosure/listedinfo/announcement/c/2013-08-26/600351_2013_z.pdf
430,2013-08-27,亚宝药业2013年半年度募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2013-08-26/600351_20130827_4.pdf
431,2013-09-25,亚宝药业关于公司全资子公司股权转让进展的公告,/disclosure/listedinfo/announcement/c/2013-09-24/600351_20130925_1.pdf
432,2013-09-25,亚宝药业：成都亚宝世纪商贸有限公司股权转让评估报告书,/disclosure/listedinfo/announcement/c/2013-09-24/600351_20130925_2.pdf
433,2013-10-09,亚宝药业2013年前三季度业绩预增公告,/disclosure/listedinfo/announcement/c/2013-10-08/600351_20131009_1.pdf
434,2013-10-29,亚宝药业第五届董事会第十四次会议决议公告,/disclosure/listedinfo/announcement/c/2013-10-28/600351_20131029_2.pdf
435,2013-10-29,亚宝药业第三季度季报,/disclosure/listedinfo/announcement/c/2013-10-28/600351_2013_3.pdf
436,2013-12-03,亚宝药业关于通过新版GMP认证的公告,/disclosure/listedinfo/announcement/c/2013-12-02/600351_20131203_1.pdf
437,2013-12-24,亚宝药业关于全资子公司生产线通过FDA认证的公告,/disclosure/listedinfo/announcement/c/2013-12-23/600351_20131224_1.pdf
438,2013-12-31,亚宝药业关于拟参与筹备设立民营银行的公告,/disclosure/listedinfo/announcement/c/2013-12-30/600351_20131231_1.pdf
439,2014-01-09,亚宝药业对外投资公告,/disclosure/listedinfo/announcement/c/2014-01-08/600351_20140109_1.pdf
440,2014-02-28,亚宝药业第五届董事会第十五次会议决议公告,/disclosure/listedinfo/announcement/c/2014-02-27/600351_20140228_1.pdf
441,2014-03-12,亚宝药业关于更换持续督导保荐代表人的公告,/disclosure/listedinfo/announcement/c/2014-03-11/600351_20140312_1.pdf
442,2014-04-25,亚宝药业年报摘要,/disclosure/listedinfo/announcement/c/2014-04-24/600351_2013_nzy.pdf
443,2014-04-25,亚宝药业年报,/disclosure/listedinfo/announcement/c/2014-04-24/600351_2013_n.pdf
444,2014-04-25,亚宝药业关于召开2013年度股东大会的通知,/disclosure/listedinfo/announcement/c/2014-04-24/600351_20140425_5.pdf
445,2014-04-25,亚宝药业关于改聘会计师事务所的公告,/disclosure/listedinfo/announcement/c/2014-04-24/600351_20140425_6.pdf
446,2014-04-25,亚宝药业独立董事提名人声明,/disclosure/listedinfo/announcement/c/2014-04-24/600351_20140425_22.pdf
447,2014-04-25,亚宝药业独立董事候选人声明,/disclosure/listedinfo/announcement/c/2014-04-24/600351_20140425_23.pdf
448,2014-04-25,亚宝药业董事会审计委员会2013年度履职报告,/disclosure/listedinfo/announcement/c/2014-04-24/600351_20140425_19.pdf
449,2014-04-25,亚宝药业第一季度季报,/disclosure/listedinfo/announcement/c/2014-04-24/600351_2014_1.pdf
450,2014-04-25,亚宝药业第五届监事会第十三次会议决议公告,/disclosure/listedinfo/announcement/c/2014-04-24/600351_20140425_4.pdf
451,2014-04-25,亚宝药业第五届董事会第十六次会议决议公告,/disclosure/listedinfo/announcement/c/2014-04-24/600351_20140425_3.pdf
452,2014-04-25,亚宝药业：民生证券股份有限公司关于亚宝药业集团股份有限公司2013年度募集资金存放与使用情况的专项核查报告,/disclosure/listedinfo/announcement/c/2014-04-24/600351_20140425_17.pdf
453,2014-04-25,亚宝药业：关于亚宝药业集团股份有限公司非经营性资金占用及其他关联资金往来的专项说明,/disclosure/listedinfo/announcement/c/2014-04-24/600351_20140425_10.pdf
454,2014-04-25,亚宝药业：关于亚宝药业集团股份有限公司2013年度募集资金存放与使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2014-04-24/600351_20140425_15.pdf
455,2014-04-25,亚宝药业：关于公司对外担保情况的专项说明和独立意见,/disclosure/listedinfo/announcement/c/2014-04-24/600351_20140425_8.pdf
456,2014-04-25,亚宝药业2013年度审计报告,/disclosure/listedinfo/announcement/c/2014-04-24/600351_20140425_9.pdf
457,2014-04-25,亚宝药业2013年度社会责任报告,/disclosure/listedinfo/announcement/c/2014-04-24/600351_20140425_14.pdf
458,2014-04-25,亚宝药业2013年度内部控制审计报告,/disclosure/listedinfo/announcement/c/2014-04-24/600351_20140425_16.pdf
459,2014-04-25,亚宝药业2013年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2014-04-24/600351_20140425_12.pdf
460,2014-04-25,亚宝药业2013年度募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2014-04-24/600351_20140425_13.pdf
461,2014-04-25,亚宝药业2013年度独立董事述职报告,/disclosure/listedinfo/announcement/c/2014-04-24/600351_20140425_11.pdf
462,2014-04-29,亚宝药业：民生证券股份有限公司关于公司2013年度现场检查工作报告,/disclosure/listedinfo/announcement/c/2014-04-28/600351_20140429_2.pdf
463,2014-04-29,亚宝药业：民生证券股份有限公司关于公司2013年持续督导年度报告书,/disclosure/listedinfo/announcement/c/2014-04-28/600351_20140429_1.pdf
464,2014-05-06,亚宝药业：民生证券股份有限公司关于亚宝药业集团股份有限公司的持续督导保荐工作总结报告书,/disclosure/listedinfo/announcement/c/2014-05-05/600351_20140506_1.pdf
465,2014-05-07,亚宝药业关于召开投资者交流会的通知,/disclosure/listedinfo/announcement/c/2014-05-06/600351_20140507_1.pdf
466,2014-05-08,亚宝药业2013年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2014-05-07/600351_20140508_1.pdf
467,2014-05-15,亚宝药业关于参加山西辖区上市公司2013年度投资者网上集体接待日活动的公告,/disclosure/listedinfo/announcement/c/2014-05-14/600351_20140515_1.pdf
468,2014-05-16,亚宝药业董事、监事年度薪酬实施办法,/disclosure/listedinfo/announcement/c/2014-05-15/600351_20140516_5.pdf
469,2014-05-16,亚宝药业第六届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2014-05-15/600351_20140516_3.pdf
470,2014-05-16,亚宝药业第六届董事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2014-05-15/600351_20140516_2.pdf
471,2014-05-16,亚宝药业2013年度股东大会律师见证法律意见书,/disclosure/listedinfo/announcement/c/2014-05-15/600351_20140516_4.pdf
472,2014-05-16,亚宝药业2013年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2014-05-15/600351_20140516_1.pdf
473,2014-05-17,亚宝药业关于投资者交流会召开情况的公告,/disclosure/listedinfo/announcement/c/2014-05-16/600351_20140517_1.pdf
474,2014-07-08,亚宝药业2013年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2014-07-07/600351_20140708_1.pdf
475,2014-08-20,亚宝药业第六届董事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2014-08-19/600351_20140820_2.pdf
476,2014-08-20,亚宝药业半年报摘要,/disclosure/listedinfo/announcement/c/2014-08-19/600351_2014_zzy.pdf
477,2014-08-20,亚宝药业半年报,/disclosure/listedinfo/announcement/c/2014-08-19/600351_2014_z.pdf
478,2014-10-18,亚宝药业关于控股股东股权质押解除的公告,/disclosure/listedinfo/announcement/c/2014-10-17/600351_20141018_1.pdf
479,2014-10-30,亚宝药业关于会计政策变更的公告,/disclosure/listedinfo/announcement/c/2014-10-29/600351_20141030_4.pdf
480,2014-10-30,亚宝药业第三季度季报,/disclosure/listedinfo/announcement/c/2014-10-29/600351_2014_3.pdf
481,2014-10-30,亚宝药业第六届监事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2014-10-29/600351_20141030_3.pdf
482,2014-10-30,亚宝药业第六届董事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2014-10-29/600351_20141030_2.pdf
483,2014-11-07,亚宝药业关于控股股东进行股票质押式回购交易的公告,/disclosure/listedinfo/announcement/c/2014-11-06/600351_20141107_1.pdf
484,2014-11-22,亚宝药业关于控股股东进行股票质押式回购交易的公告,/disclosure/listedinfo/announcement/c/2014-11-21/600351_20141122_1.pdf
485,2014-11-26,亚宝药业关于控股股东股权质押解除的公告,/disclosure/listedinfo/announcement/c/2014-11-25/600351_20141126_1.pdf
486,2014-11-28,亚宝药业关于控股股东进行股票质押式回购交易的公告,/disclosure/listedinfo/announcement/c/2014-11-27/600351_20141128_1.pdf
487,2015-01-17,亚宝药业关于通过高新技术企业复审的公告,/disclosure/listedinfo/announcement/c/2015-01-16/600351_20150117_1.pdf
488,2015-02-04,亚宝药业重大事项停牌公告,/disclosure/listedinfo/announcement/c/2015-02-03/600351_20150204_1.pdf
489,2015-02-11,亚宝药业关于筹划非公开发行股票停牌公告,/disclosure/listedinfo/announcement/c/2015-02-10/600351_20150211_1.pdf
490,2015-02-18,亚宝药业关于非公开发行股票进展暨延期复牌公告,/disclosure/listedinfo/announcement/c/2015-02-17/600351_20150218_1.pdf
491,2015-03-04,亚宝药业关于筹划非公开发行股票延期复牌的公告,/disclosure/listedinfo/announcement/c/2015-03-03/600351_20150304_1.pdf
492,2015-03-11,亚宝药业关于筹划非公开发行股票停牌进展的公告,/disclosure/listedinfo/announcement/c/2015-03-10/600351_20150311_1.pdf
493,2015-03-21,亚宝药业未来三年（2015年-2017年）股东回报规划,/disclosure/listedinfo/announcement/c/2015-03-20/600351_20150321_8.pdf
494,2015-03-21,亚宝药业募集资金管理制度,/disclosure/listedinfo/announcement/c/2015-03-20/600351_20150321_11.pdf
495,2015-03-21,亚宝药业关于修订《公司章程》的公告,/disclosure/listedinfo/announcement/c/2015-03-20/600351_20150321_5.pdf
496,2015-03-21,亚宝药业关于非公开发行股票涉及关联交易事项的公告,/disclosure/listedinfo/announcement/c/2015-03-20/600351_20150321_4.pdf
497,2015-03-21,亚宝药业关于非公开发行A股股票摊薄即期回报及填补措施的公告,/disclosure/listedinfo/announcement/c/2015-03-20/600351_20150321_6.pdf
498,2015-03-21,亚宝药业股东大会议事规则,/disclosure/listedinfo/announcement/c/2015-03-20/600351_20150321_10.pdf
499,2015-03-21,亚宝药业公司章程（2015修订）,/disclosure/listedinfo/announcement/c/2015-03-20/600351_20150321_16.pdf
500,2015-03-21,亚宝药业复牌提示性公告,/disclosure/listedinfo/announcement/c/2015-03-20/600351_20150321_7.pdf
501,2015-03-21,亚宝药业非公开发行A股股票预案,/disclosure/listedinfo/announcement/c/2015-03-20/600351_20150321_3.pdf
502,2015-03-21,亚宝药业独立董事关于修改《公司章程》中利润分配政策条款的独立意见,/disclosure/listedinfo/announcement/c/2015-03-20/600351_20150321_17.pdf
503,2015-03-21,亚宝药业独立董事关于公司非公开发行股票暨关联交易的独立意见,/disclosure/listedinfo/announcement/c/2015-03-20/600351_20150321_14.pdf
504,2015-03-21,亚宝药业独立董事关于公司《未来三年（2015年-2017年）股东回报规划》的独立意见,/disclosure/listedinfo/announcement/c/2015-03-20/600351_20150321_18.pdf
505,2015-03-21,亚宝药业独立董事关于公司2015年度非公开发行股票暨关联交易的事前认可函,/disclosure/listedinfo/announcement/c/2015-03-20/600351_20150321_13.pdf
506,2015-03-21,亚宝药业董事会审计委员会关于公司2015年度非公开发行股票涉及关联交易的事前认可函,/disclosure/listedinfo/announcement/c/2015-03-20/600351_20150321_15.pdf
507,2015-03-21,亚宝药业董事会关于前次募集资金使用情况的报告,/disclosure/listedinfo/announcement/c/2015-03-20/600351_20150321_9.pdf
508,2015-03-21,亚宝药业第六届监事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2015-03-20/600351_20150321_2.pdf
509,2015-03-21,亚宝药业第六届董事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2015-03-20/600351_20150321_1.pdf
510,2015-03-21,亚宝药业：关于亚宝药业集团股份有限公司前次募集资金使用情况的鉴证报告,/disclosure/listedinfo/announcement/c/2015-03-20/600351_20150321_19.pdf
511,2015-03-21,亚宝药业2015年度非公开发行股票募集资金使用的可行性分析报告,/disclosure/listedinfo/announcement/c/2015-03-20/600351_20150321_12.pdf
512,2015-03-26,亚宝药业实际控制人关于股票交易价格异常波动问询函的回复,/disclosure/listedinfo/announcement/c/2015-03-25/600351_20150326_3.pdf
513,2015-03-26,亚宝药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2015-03-25/600351_20150326_1.pdf
514,2015-03-26,亚宝药业：山西亚宝投资有限公司关于股票交易价格异常波动问询函的回复,/disclosure/listedinfo/announcement/c/2015-03-25/600351_20150326_2.pdf
515,2015-04-22,亚宝药业年报摘要,/disclosure/listedinfo/announcement/c/2015-04-21/600351_2014_nzy.pdf
516,2015-04-22,亚宝药业年报,/disclosure/listedinfo/announcement/c/2015-04-21/600351_2014_n.pdf
517,2015-04-22,亚宝药业关于召开2014年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2015-04-21/600351_20150422_8.pdf
518,2015-04-22,亚宝药业关于续聘会计师事务所的公告,/disclosure/listedinfo/announcement/c/2015-04-21/600351_20150422_9.pdf
519,2015-04-22,亚宝药业关于修改《公司章程》部分条款的公告,/disclosure/listedinfo/announcement/c/2015-04-21/600351_20150422_5.pdf
520,2015-04-22,亚宝药业关于向山西亚宝投资有限公司购买发明专利的关联交易公告,/disclosure/listedinfo/announcement/c/2015-04-21/600351_20150422_7.pdf
521,2015-04-22,亚宝药业股东大会议事规则,/disclosure/listedinfo/announcement/c/2015-04-21/600351_20150422_19.pdf
522,2015-04-22,亚宝药业公司章程（2015修订）,/disclosure/listedinfo/announcement/c/2015-04-21/600351_20150422_20.pdf
523,2015-04-22,亚宝药业独立董事关于第六届董事会第六次会议有关事项的专项说明和独立意见,/disclosure/listedinfo/announcement/c/2015-04-21/600351_20150422_22.pdf
524,2015-04-22,亚宝药业独立董事关联交易事前认可函,/disclosure/listedinfo/announcement/c/2015-04-21/600351_20150422_21.pdf
525,2015-04-22,亚宝药业董事会审计委员会2014年度履职报告,/disclosure/listedinfo/announcement/c/2015-04-21/600351_20150422_17.pdf
526,2015-04-22,亚宝药业第一季度季报,/disclosure/listedinfo/announcement/c/2015-04-21/600351_2015_1.pdf
527,2015-04-22,亚宝药业第六届监事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2015-04-21/600351_20150422_4.pdf
528,2015-04-22,亚宝药业第六届董事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2015-04-21/600351_20150422_3.pdf
529,2015-04-22,亚宝药业：关于亚宝药业集团股份有限公司2014年度非经营性资金占用及其他关联资金往来的专项说明,/disclosure/listedinfo/announcement/c/2015-04-21/600351_20150422_12.pdf
530,2015-04-22,亚宝药业2014年日常关联交易及2015年预计日常关联交易公告,/disclosure/listedinfo/announcement/c/2015-04-21/600351_20150422_6.pdf
531,2015-04-22,亚宝药业2014年度审计报告,/disclosure/listedinfo/announcement/c/2015-04-21/600351_20150422_11.pdf
532,2015-04-22,亚宝药业2014年度社会责任报告,/disclosure/listedinfo/announcement/c/2015-04-21/600351_20150422_15.pdf
533,2015-04-22,亚宝药业2014年度内部控制审计报告,/disclosure/listedinfo/announcement/c/2015-04-21/600351_20150422_16.pdf
534,2015-04-22,亚宝药业2014年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2015-04-21/600351_20150422_14.pdf
535,2015-04-22,亚宝药业2014年度独立董事述职报告,/disclosure/listedinfo/announcement/c/2015-04-21/600351_20150422_13.pdf
536,2015-05-07,亚宝药业更正公告,/disclosure/listedinfo/announcement/c/2015-05-06/600351_20150507_1.pdf
537,2015-05-07,亚宝药业2014年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2015-05-06/600351_20150507_2.pdf
538,2015-05-08,亚宝药业关于非公开发行股票募投项目名称更正的补充公告,/disclosure/listedinfo/announcement/c/2015-05-07/600351_20150508_1.pdf
539,2015-05-13,亚宝药业2014年年度股东大会律师见证法律意见书,/disclosure/listedinfo/announcement/c/2015-05-12/600351_20150513_2.pdf
540,2015-05-13,亚宝药业2014年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-05-12/600351_20150513_1.pdf
541,2015-05-20,亚宝药业关于参加山西辖区上市公司2014年度投资者网上集体接待日活动的公告,/disclosure/listedinfo/announcement/c/2015-05-19/600351_20150520_1.pdf
542,2015-05-22,亚宝药业2014年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2015-05-21/600351_20150522_1.pdf
543,2015-05-28,亚宝药业关于药品申报临床获得受理的公告,/disclosure/listedinfo/announcement/c/2015-05-27/600351_20150528_1.pdf
544,2015-06-02,亚宝药业关于收购贵州喜儿康药业有限公司75%股权的公告,/disclosure/listedinfo/announcement/c/2015-06-01/600351_20150602_1.pdf
545,2015-06-02,亚宝药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2015-06-01/600351_20150602_2.pdf
546,2015-06-02,亚宝药业：实际控制人关于股票交易价格异常波动问询函的回复,/disclosure/listedinfo/announcement/c/2015-06-01/600351_20150602_3.pdf
547,2015-06-02,亚宝药业：控股股东关于股票交易价格异常波动回询函的回复,/disclosure/listedinfo/announcement/c/2015-06-01/600351_20150602_4.pdf
548,2015-06-03,亚宝药业关于非公开发行股票申请获得中国证监会受理的公告,/disclosure/listedinfo/announcement/c/2015-06-02/600351_20150603_1.pdf
549,2015-06-04,亚宝药业关于实施2014年度利润分配方案后调整非公开发行股票发行价格和发行数量的公告,/disclosure/listedinfo/announcement/c/2015-06-03/600351_20150604_1.pdf
550,2015-06-24,亚宝药业关于媒体报道的澄清公告,/disclosure/listedinfo/announcement/c/2015-06-23/600351_20150624_1.pdf
551,2015-07-08,亚宝药业2015年半年度业绩预增公告,/disclosure/listedinfo/announcement/c/2015-07-07/600351_20150708_1.pdf
552,2015-07-09,亚宝药业重大事项停牌公告,/disclosure/listedinfo/announcement/c/2015-07-08/600351_20150709_1.pdf
553,2015-07-11,亚宝药业重大投资公告,/disclosure/listedinfo/announcement/c/2015-07-10/600351_20150711_2.pdf
554,2015-07-11,亚宝药业股票复牌公告,/disclosure/listedinfo/announcement/c/2015-07-10/600351_20150711_1.pdf
555,2015-07-16,亚宝药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2015-07-15/600351_20150716_1.pdf
556,2015-07-16,亚宝药业：实际控制人关于股票交易异常波动问询函的回复,/disclosure/listedinfo/announcement/c/2015-07-15/600351_20150716_3.pdf
557,2015-07-16,亚宝药业：控股股东关于股票交易异常波动情况问询函的回复,/disclosure/listedinfo/announcement/c/2015-07-15/600351_20150716_2.pdf
558,2015-08-14,亚宝药业关于召开2015年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2015-08-14/600351_20150814_4.pdf
559,2015-08-14,亚宝药业关于对运城市黄河金三角第一医院有限公司增资的公告,/disclosure/listedinfo/announcement/c/2015-08-14/600351_20150814_3.pdf
560,2015-08-14,亚宝药业第六届董事会第七次会议决议公告,/disclosure/listedinfo/announcement/c/2015-08-14/600351_20150814_2.pdf
561,2015-08-14,亚宝药业半年报摘要,/disclosure/listedinfo/announcement/c/2015-08-14/600351_2015_zzy.pdf
562,2015-08-14,亚宝药业半年报,/disclosure/listedinfo/announcement/c/2015-08-14/600351_2015_z.pdf
563,2015-08-21,亚宝药业与认购对象签订的附条件生效的股份认购合同,/disclosure/listedinfo/announcement/c/2015-08-21/600351_20150821_6.pdf
564,2015-08-21,亚宝药业与民生证券股份有限公司关于亚宝药业集团股份有限公司非公开发行股票申请文件反馈意见之回复,/disclosure/listedinfo/announcement/c/2015-08-21/600351_20150821_4.pdf
565,2015-08-21,亚宝药业关于公司最近五年被证券监管部门和交易所处罚或采取监管措施情况的公告,/disclosure/listedinfo/announcement/c/2015-08-21/600351_20150821_3.pdf
566,2015-08-21,亚宝药业关于非公开发行股票申请文件反馈意见回复的公告,/disclosure/listedinfo/announcement/c/2015-08-21/600351_20150821_1.pdf
567,2015-08-21,亚宝药业关于非公开发行A股股票摊薄即期回报及填补措施的公告,/disclosure/listedinfo/announcement/c/2015-08-21/600351_20150821_2.pdf
568,2015-08-21,亚宝药业：新余市合盛锦禾投资管理中心（有限合伙）合伙协议,/disclosure/listedinfo/announcement/c/2015-08-21/600351_20150821_7.pdf
569,2015-08-21,亚宝药业：嘉兴天璇海容创业投资合伙企业（有限合伙）合伙协议,/disclosure/listedinfo/announcement/c/2015-08-21/600351_20150821_8.pdf
570,2015-08-21,亚宝药业：关于公司非公开发行股票申请文件反馈意见回复涉及的承诺函,/disclosure/listedinfo/announcement/c/2015-08-21/600351_20150821_5.pdf
571,2015-08-21,亚宝药业：北京民生新晖投资合伙企业（有限合伙）有限合伙协议,/disclosure/listedinfo/announcement/c/2015-08-21/600351_20150821_9.pdf
572,2015-08-25,亚宝药业2015年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2015-08-25/600351_20150825_1.pdf
573,2015-09-02,亚宝药业2015年第一次临时股东大会律师见证法律意见书,/disclosure/listedinfo/announcement/c/2015-09-02/600351_20150902_2.pdf
574,2015-09-02,亚宝药业2015年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-09-02/600351_20150902_1.pdf
575,2015-10-14,亚宝药业关于控股股东及其实际控制人出具不减持公司股份承诺函的公告,/disclosure/listedinfo/announcement/c/2015-10-14/600351_20151014_3.pdf
576,2015-10-14,亚宝药业非公开发行限售股上市流通公告,/disclosure/listedinfo/announcement/c/2015-10-14/600351_20151014_1.pdf
577,2015-10-14,亚宝药业：民生证券股份有限公司关于亚宝药业集团股份有限公司限售股份上市流通之核查意见,/disclosure/listedinfo/announcement/c/2015-10-14/600351_20151014_2.pdf
578,2015-10-14,亚宝药业：承诺函（山西亚宝投资有限公司）,/disclosure/listedinfo/announcement/c/2015-10-14/600351_20151014_5.pdf
579,2015-10-14,亚宝药业：承诺函（任武贤）,/disclosure/listedinfo/announcement/c/2015-10-14/600351_20151014_4.pdf
580,2015-10-15,亚宝药业与民生证券股份有限公司关于亚宝药业集团股份有限公司非公开发行股票申请文件反馈意见之回复（修订稿）,/disclosure/listedinfo/announcement/c/2015-10-15/600351_20151015_2.pdf
581,2015-10-15,亚宝药业关于修订非公开发行股票申请文件反馈意见回复的公告,/disclosure/listedinfo/announcement/c/2015-10-15/600351_20151015_1.pdf
582,2015-10-24,亚宝药业关于非公开发行股票申请获得中国证监会发行审核委员会审核通过的公告,/disclosure/listedinfo/announcement/c/2015-10-24/600351_20151024_1.pdf
583,2015-10-28,亚宝药业第三季度季报,/disclosure/listedinfo/announcement/c/2015-10-28/600351_2015_3.pdf
584,2015-10-29,亚宝药业关于控股股东股权质押的公告,/disclosure/listedinfo/announcement/c/2015-10-29/600351_20151029_1.pdf
585,2015-11-04,亚宝药业关于控股股东进行股票质押式回购交易的公告,/disclosure/listedinfo/announcement/c/2015-11-04/600351_20151104_1.pdf
586,2015-11-05,亚宝药业关于媒体报道公司所采购的中药材延胡索检出质量问题的情况说明,/disclosure/listedinfo/announcement/c/2015-11-05/600351_20151105_1.pdf
587,2015-11-06,亚宝药业关于取得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2015-11-06/600351_20151106_1.pdf
588,2015-11-07,亚宝药业关于取得药物临床试验批件的补充公告,/disclosure/listedinfo/announcement/c/2015-11-07/600351_20151107_2.pdf
589,2015-11-07,亚宝药业关于控股股东解除股票质押式回购交易的公告,/disclosure/listedinfo/announcement/c/2015-11-07/600351_20151107_1.pdf
590,2015-11-10,亚宝药业关于控股股东进行股票质押式回购交易的公告,/disclosure/listedinfo/announcement/c/2015-11-10/600351_20151110_1.pdf
591,2015-11-19,亚宝药业关于非公开发行股票获得中国证券监督管理委员会核准批文的公告,/disclosure/listedinfo/announcement/c/2015-11-19/600351_20151119_1.pdf
592,2015-12-18,亚宝药业验资报告,/disclosure/listedinfo/announcement/c/2015-12-18/600351_20151218_2.pdf
593,2015-12-18,亚宝药业非公开发行股票发行情况报告书,/disclosure/listedinfo/announcement/c/2015-12-18/600351_20151218_5.pdf
594,2015-12-18,亚宝药业非公开发行股票发行结果暨股份变动公告,/disclosure/listedinfo/announcement/c/2015-12-18/600351_20151218_1.pdf
595,2015-12-18,亚宝药业：民生证券股份有限公司关于亚宝药业集团股份有限公司非公开发行股票的合规性说明,/disclosure/listedinfo/announcement/c/2015-12-18/600351_20151218_4.pdf
596,2015-12-18,亚宝药业：北京市海润律师事务所关于亚宝药业集团股份有限公司非公开发行股票之发行过程及认购对象合规性的法律意见书,/disclosure/listedinfo/announcement/c/2015-12-18/600351_20151218_3.pdf
597,2015-12-22,亚宝药业关于控股股东股权质押的公告,/disclosure/listedinfo/announcement/c/2015-12-22/600351_20151222_2.pdf
598,2015-12-22,亚宝药业第六届董事会第九次会议决议公告,/disclosure/listedinfo/announcement/c/2015-12-22/600351_20151222_1.pdf
599,2015-12-26,亚宝药业关于控股股东股权质押的公告,/disclosure/listedinfo/announcement/c/2015-12-26/600351_20151226_1.pdf
600,2015-12-31,亚宝药业关于上证e互动平台投资者问题回复的说明公告,/disclosure/listedinfo/announcement/c/2015-12-31/600351_20151231_3.pdf
601,2015-12-31,亚宝药业关于全资子公司取得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2015-12-31/600351_20151231_1.pdf
602,2015-12-31,亚宝药业关于控股子公司贵州喜儿康药业有限公司通过新版GMP认证的公告,/disclosure/listedinfo/announcement/c/2015-12-31/600351_20151231_2.pdf
603,2016-01-01,亚宝药业关于全资子公司取得药物临床试验批件的补充公告,/disclosure/listedinfo/announcement/c/2016-01-01/600351_20160101_1.pdf
604,2016-01-12,亚宝药业关于签订募集资金专户存储三方监管协议的公告,/disclosure/listedinfo/announcement/c/2016-01-12/600351_20160112_1.pdf
605,2016-01-13,亚宝药业关于控股股东股份解除质押的公告,/disclosure/listedinfo/announcement/c/2016-01-13/600351_20160113_1.pdf
606,2016-01-14,亚宝药业关于控股股东名称及经营范围变更的公告,/disclosure/listedinfo/announcement/c/2016-01-14/600351_20160114_1.pdf
607,2016-01-15,亚宝药业2015年年度业绩预增公告,/disclosure/listedinfo/announcement/c/2016-01-15/600351_20160115_1.pdf
608,2016-01-16,亚宝药业关于全资子公司取得药物临床试验批件及审批意见通知件的公告,/disclosure/listedinfo/announcement/c/2016-01-16/600351_20160116_1.pdf
609,2016-01-22,亚宝药业关于公司及全资子公司撤回药品注册申请的公告,/disclosure/listedinfo/announcement/c/2016-01-22/600351_20160122_1.pdf
610,2016-01-27,亚宝药业关于撤回盐酸妥洛特罗贴片药品注册申请的公告,/disclosure/listedinfo/announcement/c/2016-01-27/600351_20160127_1.pdf
611,2016-02-25,亚宝药业关于证券部办公地址及联系方式变更的公告,/disclosure/listedinfo/announcement/c/2016-02-25/600351_20160225_1.pdf
612,2016-03-08,亚宝药业关于药品获得《审批意见通知件》及全资子公司取得《药物临床试验批件》的公告,/disclosure/listedinfo/announcement/c/2016-03-08/600351_20160308_1.pdf
613,2016-03-31,亚宝药业审计报告,/disclosure/listedinfo/announcement/c/2016-03-31/600351_20160331_11.pdf
614,2016-03-31,亚宝药业年报摘要,/disclosure/listedinfo/announcement/c/2016-03-31/600351_2015_nzy.pdf
615,2016-03-31,亚宝药业年报,/disclosure/listedinfo/announcement/c/2016-03-31/600351_2015_n.pdf
616,2016-03-31,亚宝药业内部控制审计报告,/disclosure/listedinfo/announcement/c/2016-03-31/600351_20160331_16.pdf
617,2016-03-31,亚宝药业募集资金年度存放与实际使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2016-03-31/600351_20160331_19.pdf
618,2016-03-31,亚宝药业关于使用募集资金置换预先投入的自筹资金的公告,/disclosure/listedinfo/announcement/c/2016-03-31/600351_20160331_4.pdf
619,2016-03-31,亚宝药业关于公司2015年度募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2016-03-31/600351_20160331_6.pdf
620,2016-03-31,亚宝药业独立董事关于第六届董事会第十次会议有关事项的专项说明和独立意见,/disclosure/listedinfo/announcement/c/2016-03-31/600351_20160331_7.pdf
621,2016-03-31,亚宝药业董事会审计委员会2015年度履职报告,/disclosure/listedinfo/announcement/c/2016-03-31/600351_20160331_17.pdf
622,2016-03-31,亚宝药业第六届监事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2016-03-31/600351_20160331_2.pdf
623,2016-03-31,亚宝药业第六届董事会第十次会议决议公告,/disclosure/listedinfo/announcement/c/2016-03-31/600351_20160331_1.pdf
624,2016-03-31,亚宝药业：民生证券股份有限公司关于亚宝药业集团股份有限公司以募集资金置换预先投入募投项目自筹资金的核查意见,/disclosure/listedinfo/announcement/c/2016-03-31/600351_20160331_8.pdf
625,2016-03-31,亚宝药业：民生证券股份有限公司关于亚宝药业集团股份有限公司2015年度募集资金存放与使用情况的专项核查报告,/disclosure/listedinfo/announcement/c/2016-03-31/600351_20160331_18.pdf
626,2016-03-31,亚宝药业：关于亚宝药业集团股份有限公司以自筹资金预先投入募集资金投资项目情况鉴证报告,/disclosure/listedinfo/announcement/c/2016-03-31/600351_20160331_9.pdf
627,2016-03-31,亚宝药业：关于亚宝药业集团股份有限公司2015年度非经营性资金占用及其他关联资金往来的专项说明,/disclosure/listedinfo/announcement/c/2016-03-31/600351_20160331_12.pdf
628,2016-03-31,亚宝药业2015年日常关联交易及2016年预计日常关联交易公告,/disclosure/listedinfo/announcement/c/2016-03-31/600351_20160331_3.pdf
629,2016-03-31,亚宝药业2015年度社会责任报告,/disclosure/listedinfo/announcement/c/2016-03-31/600351_20160331_15.pdf
630,2016-03-31,亚宝药业2015年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2016-03-31/600351_20160331_14.pdf
631,2016-03-31,亚宝药业2015年度独立董事述职报告,/disclosure/listedinfo/announcement/c/2016-03-31/600351_20160331_13.pdf
632,2016-04-08,亚宝药业：民生证券股份有限公司关于亚宝药业集团股份有限公司2015年持续督导年度报告书,/disclosure/listedinfo/announcement/c/2016-04-08/600351_20160408_1.pdf
633,2016-04-20,亚宝药业关于全资子公司北京亚宝生物药业有限公司的制剂产品氢溴酸加兰他敏片获得美国FDA批准文号的公告,/disclosure/listedinfo/announcement/c/2016-04-20/600351_20160420_1.pdf
634,2016-04-29,亚宝药业关于召开2015年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2016-04-29/600351_20160429_4.pdf
635,2016-04-29,亚宝药业关于与上海清松制药有限公司签署技术开发和技术转让合同的关联交易公告,/disclosure/listedinfo/announcement/c/2016-04-29/600351_20160429_3.pdf
636,2016-04-29,亚宝药业关于亚宝药业集团股份有限公司与上海清松制药有限公司签署技术开发和技术转让合同的独立董事意见,/disclosure/listedinfo/announcement/c/2016-04-29/600351_20160429_6.pdf
637,2016-04-29,亚宝药业第六届董事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2016-04-29/600351_20160429_2.pdf
638,2016-04-29,亚宝药业2016年第一季度报告,/disclosure/listedinfo/announcement/c/2016-04-29/600351_2016_1.pdf
639,2016-05-05,亚宝药业关于副总经理辞职的公告,/disclosure/listedinfo/announcement/c/2016-05-05/600351_20160505_1.pdf
640,2016-05-18,亚宝药业2015年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2016-05-18/600351_20160518_1.pdf
641,2016-05-25,亚宝药业2015年年度股东大会律师见证法律意见书,/disclosure/listedinfo/announcement/c/2016-05-25/600351_20160525_2.pdf
642,2016-05-25,亚宝药业2015年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-05-25/600351_20160525_1.pdf
643,2016-05-26,亚宝药业关于参加山西辖区上市公司2016年投资者网上集体接待日活动的公告,/disclosure/listedinfo/announcement/c/2016-05-26/600351_20160526_1.pdf
644,2016-06-07,亚宝药业关于控股子公司亚宝北中大（北京）制药有限公司出售资产的公告,/disclosure/listedinfo/announcement/c/2016-06-07/600351_20160607_1.pdf
645,2016-06-07,亚宝药业：亚宝北中大房地产评估报告,/disclosure/listedinfo/announcement/c/2016-06-07/600351_20160607_2.pdf
646,2016-06-22,亚宝药业2015年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2016-06-22/600351_20160622_1.pdf
647,2016-06-23,亚宝药业关于取得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-06-23/600351_20160623_1.pdf
648,2016-07-01,亚宝药业关于媒体报道的澄清公告,/disclosure/listedinfo/announcement/c/2016-07-01/600351_20160701_1.pdf
649,2016-07-02,亚宝药业关于媒体报道的澄清补充公告,/disclosure/listedinfo/announcement/c/2016-07-02/600351_20160702_1.pdf
650,2016-07-06,亚宝药业关于媒体报道的澄清补充公告,/disclosure/listedinfo/announcement/c/2016-07-06/600351_20160706_1.pdf
651,2016-07-29,亚宝药业关于控股股东股份质押的公告,/disclosure/listedinfo/announcement/c/2016-07-29/600351_20160729_1.pdf
652,2016-08-10,亚宝药业关于控股股东股份解除质押的公告,/disclosure/listedinfo/announcement/c/2016-08-10/600351_20160810_1.pdf
653,2016-08-16,亚宝药业关于控股股东股份解除质押的公告,/disclosure/listedinfo/announcement/c/2016-08-16/600351_20160816_1.pdf
654,2016-08-27,亚宝药业关于2016年半年度募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2016-08-27/600351_20160827_4.pdf
655,2016-08-27,亚宝药业第六届监事会第十次会议决议公告,/disclosure/listedinfo/announcement/c/2016-08-27/600351_20160827_3.pdf
656,2016-08-27,亚宝药业第六届董事会第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2016-08-27/600351_20160827_2.pdf
657,2016-08-27,亚宝药业2016年半年度报告摘要,/disclosure/listedinfo/announcement/c/2016-08-27/600351_2016_zzy.pdf
658,2016-08-27,亚宝药业2016年半年度报告,/disclosure/listedinfo/announcement/c/2016-08-27/600351_2016_z.pdf
659,2016-09-22,亚宝药业因股权收购行为涉及的上海清松制药有限公司股东全部权益价值评估报告,/disclosure/listedinfo/announcement/c/2016-09-22/600351_20160922_11.pdf
660,2016-09-22,亚宝药业审计委员会关于第六届董事会第十三次会议有关事项的审核意见,/disclosure/listedinfo/announcement/c/2016-09-22/600351_20160922_14.pdf
661,2016-09-22,亚宝药业关于召开2016年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2016-09-22/600351_20160922_6.pdf
662,2016-09-22,亚宝药业关于修改《公司章程》的公告,/disclosure/listedinfo/announcement/c/2016-09-22/600351_20160922_4.pdf
663,2016-09-22,亚宝药业关于收购上海清松制药有限公司75%股权暨关联交易公告,/disclosure/listedinfo/announcement/c/2016-09-22/600351_20160922_5.pdf
664,2016-09-22,亚宝药业关于改聘会计师事务所的公告,/disclosure/listedinfo/announcement/c/2016-09-22/600351_20160922_3.pdf
665,2016-09-22,亚宝药业公司章程（2016年9月修订）,/disclosure/listedinfo/announcement/c/2016-09-22/600351_20160922_7.pdf
666,2016-09-22,亚宝药业独立董事关于第六届董事会第十三次会议有关事项的独立意见,/disclosure/listedinfo/announcement/c/2016-09-22/600351_20160922_9.pdf
667,2016-09-22,亚宝药业独立董事关联交易事前认可函,/disclosure/listedinfo/announcement/c/2016-09-22/600351_20160922_8.pdf
668,2016-09-22,亚宝药业第六届监事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2016-09-22/600351_20160922_2.pdf
669,2016-09-22,亚宝药业第六届董事会第十三次会议决议公告,/disclosure/listedinfo/announcement/c/2016-09-22/600351_20160922_1.pdf
670,2016-09-22,亚宝药业：上海清松制药有限公司盈利预测审核报告,/disclosure/listedinfo/announcement/c/2016-09-22/600351_20160922_12.pdf
671,2016-09-22,亚宝药业：上海清松制药有限公司2015年度及2016年1-6月财务报表及审计报告,/disclosure/listedinfo/announcement/c/2016-09-22/600351_20160922_10.pdf
672,2016-09-22,亚宝药业：民生证券股份有限公司关于亚宝药业集团股份有限公司收购资产暨关联交易之核查意见,/disclosure/listedinfo/announcement/c/2016-09-22/600351_20160922_13.pdf
673,2016-09-28,亚宝药业2016年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2016-09-28/600351_20160928_1.pdf
674,2016-10-12,亚宝药业2016年前三季度业绩预减公告,/disclosure/listedinfo/announcement/c/2016-10-12/600351_20161012_2.pdf
675,2016-10-12,亚宝药业2016年第一次临时股东大会律师见证法律意见书,/disclosure/listedinfo/announcement/c/2016-10-12/600351_20161012_3.pdf
676,2016-10-12,亚宝药业2016年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-10-12/600351_20161012_1.pdf
677,2016-10-20,亚宝药业关于控股股东股份质押的公告,/disclosure/listedinfo/announcement/c/2016-10-20/600351_20161020_1.pdf
678,2016-10-26,亚宝药业2016年第三季度报告,/disclosure/listedinfo/announcement/c/2016-10-26/600351_2016_3.pdf
679,2016-10-29,亚宝药业关于收购上海清松制药有限公司75%股权完成工商变更登记的公告,/disclosure/listedinfo/announcement/c/2016-10-29/600351_20161029_2.pdf
680,2016-10-29,亚宝药业关于控股股东股票质押式回购交易到期购回的公告,/disclosure/listedinfo/announcement/c/2016-10-29/600351_20161029_1.pdf
681,2016-11-02,亚宝药业关于媒体报道的澄清公告,/disclosure/listedinfo/announcement/c/2016-11-02/600351_20161102_1.pdf
682,2016-11-04,亚宝药业关于控股股东股票质押式回购交易到期购回的公告,/disclosure/listedinfo/announcement/c/2016-11-04/600351_20161104_1.pdf
683,2016-12-01,亚宝药业关于控股股东进行股票质押式回购交易的公告,/disclosure/listedinfo/announcement/c/2016-12-01/600351_20161201_1.pdf
684,2016-12-03,亚宝药业关于控股股东股票质押式回购交易到期购回的公告,/disclosure/listedinfo/announcement/c/2016-12-03/600351_20161203_1.pdf
685,2016-12-10,亚宝药业关于药品临床试验申请获得受理的公告,/disclosure/listedinfo/announcement/c/2016-12-10/600351_20161210_1.pdf
686,2016-12-22,亚宝药业：民生证券股份有限公司关于亚宝药业集团股份有限公司非公开发行股票持续督导之2016年度现场检查报告,/disclosure/listedinfo/announcement/c/2016-12-22/600351_20161222_1.pdf
687,2017-01-20,亚宝药业2016年年度业绩预减公告,/disclosure/listedinfo/announcement/c/2017-01-20/600351_20170120_1.pdf
688,2017-02-14,亚宝药业关于获得药物临床试验批件和审批意见通知件的公告,/disclosure/listedinfo/announcement/c/2017-02-14/600351_20170214_1.pdf
689,2017-02-17,亚宝药业关于媒体报道的澄清公告,/disclosure/listedinfo/announcement/c/2017-02-17/600351_20170217_1.pdf
690,2017-04-27,亚宝药业关于召开2016年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2017-04-27/600351_20170427_7.pdf
691,2017-04-27,亚宝药业关于变更部分募集资金投资项目的公告,/disclosure/listedinfo/announcement/c/2017-04-27/600351_20170427_6.pdf
692,2017-04-27,亚宝药业关于2016年年度募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2017-04-27/600351_20170427_5.pdf
693,2017-04-27,亚宝药业独立董事关于第六届董事会第十五次会议有关事项的专项说明和独立意见,/disclosure/listedinfo/announcement/c/2017-04-27/600351_20170427_10.pdf
694,2017-04-27,亚宝药业董事会审计委员会2016年度履职报告,/disclosure/listedinfo/announcement/c/2017-04-27/600351_20170427_24.pdf
695,2017-04-27,亚宝药业第六届监事会第十三次会议决议公告,/disclosure/listedinfo/announcement/c/2017-04-27/600351_20170427_3.pdf
696,2017-04-27,亚宝药业第六届董事会第十五次会议决议公告,/disclosure/listedinfo/announcement/c/2017-04-27/600351_20170427_2.pdf
697,2017-04-27,亚宝药业：民生证券股份有限公司关于亚宝药业集团股份有限公司变更部分募集资金投资项目之核查意见,/disclosure/listedinfo/announcement/c/2017-04-27/600351_20170427_15.pdf
698,2017-04-27,亚宝药业：民生证券股份有限公司关于亚宝药业集团股份有限公司2016年度募集资金存放与实际使用情况的专项核查报告,/disclosure/listedinfo/announcement/c/2017-04-27/600351_20170427_11.pdf
699,2017-04-27,亚宝药业：民生证券股份有限公司关于亚宝药业集团股份有限公司2016年持续督导年度报告书,/disclosure/listedinfo/announcement/c/2017-04-27/600351_20170427_13.pdf
700,2017-04-27,亚宝药业：民生证券股份有限公司关于亚宝药业集团股份有限公司2015年非公开发行股票持续督导之保荐工作总结报告书,/disclosure/listedinfo/announcement/c/2017-04-27/600351_20170427_14.pdf
701,2017-04-27,亚宝药业：关于亚宝药业集团股份有限公司控股股东及其他关联方占用资金情况的专项说明,/disclosure/listedinfo/announcement/c/2017-04-27/600351_20170427_18.pdf
702,2017-04-27,亚宝药业：关于亚宝药业集团股份有限公司2016年度募集资金存放与使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2017-04-27/600351_20170427_12.pdf
703,2017-04-27,亚宝药业：关于上海清松制药有限公司原股东对上海清松制药有限公司2016年度业绩承诺实现情况的说明审核报告,/disclosure/listedinfo/announcement/c/2017-04-27/600351_20170427_22.pdf
704,2017-04-27,亚宝药业：2016年度审计报告,/disclosure/listedinfo/announcement/c/2017-04-27/600351_20170427_17.pdf
705,2017-04-27,亚宝药业：2016年度内部控制审计报告,/disclosure/listedinfo/announcement/c/2017-04-27/600351_20170427_23.pdf
706,2017-04-27,亚宝药业2017年第一季度报告,/disclosure/listedinfo/announcement/c/2017-04-27/600351_2017_1.pdf
707,2017-04-27,亚宝药业2016年日常关联交易及2017年预计日常关联交易公告,/disclosure/listedinfo/announcement/c/2017-04-27/600351_20170427_4.pdf
708,2017-04-27,亚宝药业2016年年度报告摘要,/disclosure/listedinfo/announcement/c/2017-04-27/600351_2016_nzy.pdf
709,2017-04-27,亚宝药业2016年年度报告,/disclosure/listedinfo/announcement/c/2017-04-27/600351_2016_n.pdf
710,2017-04-27,亚宝药业2016年度社会责任报告,/disclosure/listedinfo/announcement/c/2017-04-27/600351_20170427_21.pdf
711,2017-04-27,亚宝药业2016年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2017-04-27/600351_20170427_20.pdf
712,2017-04-27,亚宝药业2016年度独立董事述职报告,/disclosure/listedinfo/announcement/c/2017-04-27/600351_20170427_19.pdf
713,2017-05-10,亚宝药业2016年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-05-10/600351_20170510_1.pdf
714,2017-05-18,亚宝药业独立董事对第七届董事会第一次会议聘任高级管理人员的独立意见,/disclosure/listedinfo/announcement/c/2017-05-18/600351_20170518_4.pdf
715,2017-05-18,亚宝药业第七届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2017-05-18/600351_20170518_5.pdf
716,2017-05-18,亚宝药业第七届董事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2017-05-18/600351_20170518_3.pdf
717,2017-05-18,亚宝药业2016年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-05-18/600351_20170518_1.pdf
718,2017-05-18,亚宝药业2016年度股东大会律师见证法律意见书,/disclosure/listedinfo/announcement/c/2017-05-18/600351_20170518_2.pdf
719,2017-05-20,亚宝药业关于实际控制人之一致行动人及高管增持公司股份的公告,/disclosure/listedinfo/announcement/c/2017-05-20/600351_20170520_1.pdf
720,2017-06-07,亚宝药业关于收到业绩承诺补偿款的公告,/disclosure/listedinfo/announcement/c/2017-06-07/600351_20170607_2.pdf
721,2017-06-15,亚宝药业关于参加山西辖区上市公司2017年投资者网上集体接待日活动的公告,/disclosure/listedinfo/announcement/c/2017-06-15/600351_20170615_1.pdf
722,2017-06-16,亚宝药业关于签订募集资金专户存储三方监管协议的公告,/disclosure/listedinfo/announcement/c/2017-06-16/600351_20170616_1.pdf
723,2017-06-24,亚宝药业2016年年度权益分派实施公告,/disclosure/listedinfo/announcement/c/2017-06-24/600351_20170624_1.pdf
724,2017-07-22,亚宝药业2017年半年度业绩快报公告,/disclosure/listedinfo/announcement/c/2017-07-22/600351_20170722_1.pdf
725,2017-07-28,亚宝药业关于控股股东进行股票质押式回购交易的公告,/disclosure/listedinfo/announcement/c/2017-07-28/600351_20170728_1.pdf
726,2017-07-29,亚宝药业关于获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2017-07-29/600351_20170729_1.pdf
727,2017-08-03,亚宝药业关于控股股东股份解除质押的公告,/disclosure/listedinfo/announcement/c/2017-08-03/600351_20170803_1.pdf
728,2017-08-19,亚宝药业关于2017年半年度募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2017-08-19/600351_20170819_8.pdf
729,2017-08-19,亚宝药业高级管理人员年度薪酬实施办法,/disclosure/listedinfo/announcement/c/2017-08-19/600351_20170819_6.pdf
730,2017-08-19,亚宝药业独立董事关于修订董事、监事及高级管理人员薪酬实施办法的独立意见,/disclosure/listedinfo/announcement/c/2017-08-19/600351_20170819_4.pdf
731,2017-08-19,亚宝药业董事、监事年度薪酬实施办法,/disclosure/listedinfo/announcement/c/2017-08-19/600351_20170819_5.pdf
732,2017-08-19,亚宝药业第七届监事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2017-08-19/600351_20170819_7.pdf
733,2017-08-19,亚宝药业第七届董事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2017-08-19/600351_20170819_3.pdf
734,2017-08-19,亚宝药业2017年半年度报告摘要,/disclosure/listedinfo/announcement/c/2017-08-19/600351_2017_zzy.pdf
735,2017-08-19,亚宝药业2017年半年度报告,/disclosure/listedinfo/announcement/c/2017-08-19/600351_2017_z.pdf
736,2017-09-07,亚宝药业关于控股股东进行股票质押式回购交易的公告,/disclosure/listedinfo/announcement/c/2017-09-07/600351_20170907_1.pdf
737,2017-09-15,亚宝药业关于媒体报道的澄清公告,/disclosure/listedinfo/announcement/c/2017-09-15/600351_20170915_1.pdf
738,2017-09-27,亚宝药业2017年前三季度业绩预增公告,/disclosure/listedinfo/announcement/c/2017-09-27/600351_20170927_1.pdf
739,2017-10-21,亚宝药业2017年第三季度报告,/disclosure/listedinfo/announcement/c/2017-10-21/600351_2017_3.pdf
740,2017-11-09,亚宝药业简式权益变动报告书,/disclosure/listedinfo/announcement/c/2017-11-09/600351_20171109_2.pdf
741,2017-11-09,亚宝药业关于股东权益变动的提示性公告,/disclosure/listedinfo/announcement/c/2017-11-09/600351_20171109_1.pdf
742,2017-11-11,亚宝药业关于控股股东拟非公开发行可交换公司债券的公告,/disclosure/listedinfo/announcement/c/2017-11-11/600351_20171111_1.pdf
743,2017-11-14,亚宝药业关于终止筹建民营银行的公告,/disclosure/listedinfo/announcement/c/2017-11-14/600351_20171114_1.pdf
744,2017-11-16,亚宝药业关于药品临床试验申请获得受理的公告,/disclosure/listedinfo/announcement/c/2017-11-16/600351_20171116_1.pdf
745,2017-11-23,亚宝药业关于媒体报道的澄清公告,/disclosure/listedinfo/announcement/c/2017-11-23/600351_20171123_1.pdf
746,2017-12-01,亚宝药业关于控股股东进行股票质押式回购交易并解除部分股份质押的公告,/disclosure/listedinfo/announcement/c/2017-12-01/600351_20171201_1.pdf
747,2017-12-06,亚宝药业关于控股股东进行股票质押式回购交易的公告,/disclosure/listedinfo/announcement/c/2017-12-06/600351_20171206_1.pdf
748,2017-12-26,亚宝药业2017年年度业绩预增公告,/disclosure/listedinfo/announcement/c/2017-12-26/600351_20171226_1.pdf
749,2018-01-26,亚宝药业2017年年度业绩预增公告,/disclosure/listedinfo/announcement/c/2018-01-26/600351_20180126_1.pdf
